Document:

EX-10.45

 Exhibit 10.45 

EXECUTION COPY 
  

 
  

AQUA PENNSYLVANIA, INC. 

$25,000,000 First Mortgage Bonds, 3.94% Series due 2031 

$25,000,000 First Mortgage Bonds, 4.61% Series due 2045 

$25,000,000 First Mortgage Bonds, 4.62% Series due 2046 
  

 

BOND PURCHASE AGREEMENT 

 
  

Dated as of October 24, 2013 
  

 
  

 TABLE OF CONTENTS 

 

							
		 		  	 	PAGE	  
			
	 SECTION
	 	HEADING	  			
			
	 SECTION 1.
	 	AUTHORIZATION OF BONDS	  	 	1	  
			
	 SECTION 2.
	 	SALE AND PURCHASE OF BONDS	  	 	2	  
			
	 SECTION 3.
	 	CLOSING	  	 	2	  
			
	 SECTION 4.
	 	CONDITIONS TO CLOSING	  	 	2	  
			
	 Section 4.1.
	 	Representations and Warranties	  	 	2	  
	 Section 4.2.
	 	Performance; No Default	  	 	2	  
	 Section 4.3.
	 	Compliance Certificates	  	 	3	  
	 Section 4.4.
	 	Opinions of Counsel	  	 	3	  
	 Section 4.5.
	 	Purchase Permitted by Applicable Law, Etc	  	 	3	  
	 Section 4.6.
	 	Sale of Bonds	  	 	4	  
	 Section 4.7.
	 	Payment of Special Counsel Fees	  	 	4	  
	 Section 4.8.
	 	Private Placement Number	  	 	4	  
	 Section 4.9.
	 	Changes in Corporate Structure	  	 	4	  
	 Section 4.10.
	 	Funding Instructions	  	 	4	  
	 Section 4.11.
	 	Proceedings and Documents	  	 	4	  
	 Section 4.12.
	 	Execution and Delivery and Filing and Recording of the Supplement	  	 	4	  
	 Section 4.13.
	 	Regulatory Approvals	  	 	5	  
			
	 SECTION 5.
	 	REPRESENTATIONS AND WARRANTIES OF THE COMPANY	  	 	5	  
			
	 Section 5.1.
	 	Organization; Power and Authority	  	 	5	  
	 Section 5.2.
	 	Authorization, Etc	  	 	5	  
	 Section 5.3.
	 	Disclosure	  	 	5	  
	 Section 5.4.
	 	Organization and Ownership of Shares of Subsidiaries	  	 	6	  
	 Section 5.5.
	 	Financial Statements; Material Liabilities	  	 	6	  
	 Section 5.6.
	 	Compliance with Laws, Other Instruments, Etc	  	 	6	  
	 Section 5.7.
	 	Governmental Authorizations, Etc	  	 	7	  
	 Section 5.8.
	 	Litigation; Observance of Statutes and Orders	  	 	7	  
	 Section 5.9.
	 	Taxes	  	 	7	  
	 Section 5.10.
	 	Title to Property; Leases	  	 	8	  
	 Section 5.11.
	 	Licenses, Permits, Etc	  	 	8	  
	 Section 5.12.
	 	Compliance with ERISA	  	 	8	  
	 Section 5.13.
	 	Private Offering by the Company	  	 	9	  
	 Section 5.14.
	 	Use of Proceeds; Margin Regulations	  	 	9	  
	 Section 5.15.
	 	Existing Debt	  	 	9	  
	 Section 5.16.
	 	Foreign Assets Control Regulations, Etc	  	 	10	  
	 Section 5.17.
	 	Status under Certain Statutes	  	 	10	  

  
 -i- 

							
	 Section 5.18.
	 	Environmental Matters	  	 	11	  
	 Section 5.19.
	 	Lien of Indenture	  	 	11	  
	 Section 5.20.
	 	Filings	  	 	11	  
			
	 SECTION 6.
	 	REPRESENTATIONS OF THE PURCHASERS	  	 	12	  
			
	 Section 6.1.
	 	Purchase for Investment	  	 	12	  
	 Section 6.2.
	 	Source of Funds	  	 	12	  
			
	 SECTION 7.
	 	INFORMATION AS TO COMPANY	  	 	14	  
			
	 Section 7.1.
	 	Financial and Business Information	  	 	14	  
	 Section 7.2
	 	Officer’s Certificate	  	 	16	  
	 Section 7.3.
	 	Visitation	  	 	17	  
			
	 SECTION 8.
	 	PURCHASE OF BONDS	  	 	17	  
			
	 SECTION 9.
	 	AFFIRMATIVE COVENANTS	  	 	17	  
			
	 Section 9.1.
	 	Compliance with Law	  	 	17	  
	 Section 9.2.
	 	Insurance	  	 	18	  
	 Section 9.3.
	 	Maintenance of Properties	  	 	18	  
	 Section 9.4.
	 	Payment of Taxes	  	 	18	  
	 Section 9.5.
	 	Corporate Existence, Etc	  	 	18	  
	 Section 9.6.
	 	Books and Records	  	 	18	  
			
	 SECTION 10.
	 	NEGATIVE COVENANTS	  	 	19	  
			
	 Section 10.1.
	 	Transactions with Affiliates	  	 	19	  
	 Section 10.2.
	 	Merger, Consolidation, Etc	  	 	19	  
	 Section 10.3.
	 	Line of Business	  	 	19	  
	 Section 10.4.
	 	Terrorism Sanctions Regulations	  	 	19	  
			
	 SECTION 11.
	 	PAYMENTS ON BONDS	  	 	20	  
			
	 Section 11.1.
	 	Home Office Payment	  	 	20	  
			
	 SECTION 12.
	 	REGISTRATION; EXCHANGE; EXPENSES, ETC	  	 	20	  
			
	 Section 12.1.
	 	Registration of Bonds	  	 	20	  
	 Section 12.2.
	 	Transaction Expenses	  	 	20	  
	 Section 12.3.
	 	Survival	  	 	21	  
			
	 SECTION 13.
	 	SURVIVAL OF REPRESENTATIONS AND WARRANTIES; ENTIRE AGREEMENT	  	 	21	  
			
	 SECTION 14.
	 	AMENDMENT AND WAIVER	  	 	21	  
			
	 Section 14.1.
	 	Requirements	  	 	21	  

  
 -ii- 

							
	 Section 14.2.
	 	Solicitation of Holders of Bonds	  	 	21	  
	 Section 14.3.
	 	Binding Effect, Etc	  	 	22	  
	 Section 14.4.
	 	Bonds Held by Company, Etc	  	 	22	  
			
	 SECTION 15.
	 	NOTICES	  	 	23	  
			
	 SECTION 16.
	 	INDEMNIFICATION	  	 	23	  
			
	 SECTION 17.
	 	REPRODUCTION OF DOCUMENTS	  	 	23	  
			
	 SECTION 18.
	 	CONFIDENTIAL INFORMATION	  	 	24	  
			
	 SECTION 19.
	 	MISCELLANEOUS	  	 	25	  
			
	 Section 19.1.
	 	Successors and Assigns	  	 	25	  
	 Section 19.2.
	 	Accounting Terms	  	 	25	  
	 Section 19.3.
	 	Severability	  	 	25	  
	 Section 19.4.
	 	Construction, Etc	  	 	25	  
	 Section 19.5.
	 	Counterparts	  	 	26	  
	 Section 19.6.
	 	Governing Law	  	 	26	  
	 Section 19.7.
	 	Jurisdiction and Process; Waiver of Jury Trial	  	 	26	  
	 Section 19.8.
	 	Payments Due on Non-Business Days	  	 	27	  

  
 -iii- 

					
	Schedule A	 	—	  	Information Relating to Purchasers
	Schedule B	 	—	  	Defined Terms
	Schedule 5.4	 	—	  	Subsidiaries of the Company and Ownership of Subsidiary Stock
	Schedule 5.5	 	—	  	Financial Statements
	Schedule 5.15(a)	 	—	  	Existing Debt
	Schedule 5.15(b)	 	—	  	Debt Instruments
	Exhibit A	 	—	  	Form of Forty-eighth Supplemental Indenture
	Exhibit 4.4(a)	 	—	  	Form of Opinion of Counsel for the Company
	Exhibit 4.4(b)	 	—	  	Form of Opinion of Special Counsel for the Company
	Exhibit 4.4 (c)	 		  	Form of Opinion of Special Counsel for the Purchasers

  
 -iv- 

 AQUA PENNSYLVANIA, INC. 

762 West Lancaster Avenue 
 Bryn
Mawr, Pennsylvania 19010-3489 
 $25,000,000 First Mortgage Bonds, 3.94% Series due 2031 

$25,000,000 First Mortgage Bonds, 4.61% Series due 2045 

$25,000,000 First Mortgage Bonds, 4.62% Series due 2046 

October 24, 2013 
 To Each of The Purchasers
Listed in 
 Schedule A Hereto: 
 Ladies and Gentlemen: 

Aqua Pennsylvania, Inc., a corporation organized under the laws of the Commonwealth of Pennsylvania (the “Company”), agrees
with each of the purchasers whose names appear at the end hereof (each, a “Purchaser” and, collectively, the “Purchasers”) as follows: 

SECTION 1. AUTHORIZATION OF BONDS. 

The Company will authorize the issue and sale of (i) $25,000,000 First Mortgage Bonds, 3.94% Series due November 1, 2031 (the
“Series A Bonds”), (ii) $25,000,000 First Mortgage Bonds, 4.61% Series due November 1, 2045 (the “Series A Bonds”) and (ii) $25,000,000 First Mortgage Bonds, 4.62% Series due November 1, 2046
(the “Series C Bonds” and together with the Series A Bonds and the Series B Bonds, the “Bonds”) and such term includes any such notes issued in substitution therefor). The Bonds will be issued under and secured by
that certain Indenture of Mortgage dated as of January 1, 1941, from the Company (as successor by merger to the Philadelphia Suburban Water Company), as grantor, to The Bank of New York Trust Company, N.A., as successor trustee (the
“Trustee”) (the “Original Indenture”), as previously amended and supplemented by forty-seven supplemental indentures and as further supplemented by the Forty-eighth
Supplemental Indenture dated as of October 1, 2013 (such Forty-eighth Supplemental Indenture being referred to herein as the “Supplement”) which will be substantially in the form attached hereto as Exhibit A, with such
changes therein, if any, as shall be approved by the Purchasers and the Company. The Original Indenture, as supplemented and amended by the aforementioned forty-seven supplemental indentures and the
Supplement, and as further supplemented or amended according to its terms, is hereinafter referred to as the “Indenture”. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a
“Schedule” or an “Exhibit” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement. Terms used herein but not defined herein shall have the meanings set forth in the Indenture. 

 SECTION 2. SALE AND PURCHASE OF
BONDS. 
 Subject to the terms and conditions of this Agreement, the Company will issue and sell to each Purchaser and each
Purchaser will purchase from the Company, at the Closing provided for in Section 3, Bonds in the principal amount and in the series specified opposite such Purchaser’s name in Schedule A at the purchase price of 100% of the principal
amount thereof. The Purchasers’ obligations hereunder are several and not joint obligations and no Purchaser shall have any liability to any Person for the performance or non-performance of any obligation
by any other Purchaser hereunder. 
 SECTION 3. CLOSING. 

The execution and delivery of this Agreement and the sale and purchase of the Bonds to be purchased by each Purchaser shall occur at the
offices of Chapman and Cutler LLP, 111 West Monroe Street, Chicago, Illinois 60603, at 10:00 a.m., Chicago time, at a closing (the “Closing”) on October 24, 2013 or on such other Business Day thereafter on or prior to
November 1, 2013 as may be agreed upon by the Company and the Purchasers. At the Closing the Company will deliver to each Purchaser the Bonds to be purchased by such Purchaser in the form of one or more Bonds in each series to be purchased by
such Purchaser, as applicable, in such denominations as such Purchaser may request (with a minimum denomination of $100,000 for each Bond), dated the date of the Closing and registered in such Purchaser’s name (or in the name of its nominee),
against delivery by such Purchaser to the Company or its order of immediately available funds in the amount of the purchase price therefor by wire transfer of immediately available funds for Account Number: 8559742757, Account Name: Aqua
Pennsylvania, Inc., at PNC Bank, N.A., Philadelphia, Pennsylvania, ABA Number 031-000053. If at the Closing the Company shall fail to tender such Bonds to any Purchaser as provided above in this
Section 3, or any of the conditions specified in Section 4 shall not have been fulfilled to such Purchaser’s satisfaction, such Purchaser shall, at its election, be relieved of all further obligations under this Agreement, without
thereby waiving any rights such Purchaser may have by reason of such failure or such nonfulfillment. 
 SECTION 4.
CONDITIONS TO CLOSING. 
 Each Purchaser’s obligation to execute and deliver this Agreement
and to purchase and pay for the Bonds to be sold to such Purchaser prior to or at the Closing is subject to the fulfillment to such Purchaser’s satisfaction at the Closing of the following conditions: 

Section 4.1. Representations and Warranties. The representations and warranties of the Company in this Agreement shall be correct
when made and at the time of the Closing. 
 Section 4.2. Performance; No Default. The Company shall have performed and complied
with all agreements and conditions contained in each Financing Agreement required to be performed or complied with by the Company prior to or at the Closing, and after giving effect to the issue and sale of the Bonds (and the application of the
proceeds thereof as contemplated by Section 5.14), no Default or Event of Default shall have occurred and be continuing. 

  
 -2- 

 Section 4.3. Compliance Certificates. The Company shall have performed and complied
with all agreements and conditions contained in the Indenture which are required to be performed or complied with by the Company for the issuance of the Bonds. In addition the Company shall have delivered the following certificates: 

(a) Officer’s Certificate. The Company shall have delivered to such Purchaser (i) an Officer’s
Certificate, dated the date of the Closing, certifying that the conditions specified in Section 4 of this Agreement have been fulfilled, and (ii) copies of all certificates and opinions required to be delivered to the Trustee under the
Indenture in connection with the issuance of the Bonds under the Indenture, in each case, dated the date of the Closing. 

(b) Secretary’s Certificate. The Company shall have delivered to such Purchaser a certificate of its Secretary or
Assistant Secretary, dated the date of the Closing, certifying as to the resolutions attached thereto and other corporate proceedings relating to the authorization, execution and delivery of this Agreement, the Bonds and the Supplement. 

(c) Certification of Indenture. Each Purchaser shall have received a composite copy of the Indenture (together with all
amendments and supplements thereto), certified by the Company as of the date of the Closing, exclusive of property exhibits, recording information and the like. 

Section 4.4. Opinions of Counsel. Such Purchaser shall have received opinions in form and substance satisfactory to such
Purchaser, dated the date of the Closing (a) from Christopher P. Luning, counsel for the Company, covering the matters set forth in Exhibit 4.4(a) and covering such other matters incident to the transactions contemplated hereby as such
Purchaser or its counsel may reasonably request (and the Company hereby instructs its counsel to deliver such opinion to the Purchasers) and (b) from Dilworth Paxson, LLP, special counsel to the Company, covering the matters set forth in
Exhibit 4.4(b) and covering such other matters incident to the transactions contemplated hereby as the Purchaser or the Purchaser’s counsel may reasonably request (and the Company hereby instructs its counsel to deliver such opinion to the
Purchasers), and (c) from Chapman and Cutler LLP, the Purchasers’ special counsel in connection with such transactions, substantially in the form set forth in Exhibit 4.4(c) and covering such other matters incident to such transactions as
such Purchaser may reasonably request. The Company hereby directs its counsel to deliver the opinions required by this Section 4.4 and understands and agrees that each Purchaser will and hereby is authorized to rely on such opinions. 

Section 4.5. Purchase Permitted by Applicable Law, Etc. On the date of the Closing such Purchaser’s purchase of Bonds shall
(a) be permitted by the laws and regulations of each jurisdiction to which such Purchaser is subject, without recourse to provisions (such as section 1405(a)(8) of the New York Insurance Law) permitting limited investments by
insurance companies without restriction as to the character of the particular investment, (b) not violate any applicable law or regulation (including, without limitation, Regulation T, U or X of the Board of Governors of the Federal
Reserve System) and (c) not subject such Purchaser to any tax, penalty or liability under or pursuant to any applicable law or regulation, which law or regulation was not in effect on the date of the Closing. If requested by such Purchaser,
such Purchaser shall have received an Officer’s Certificate certifying as to such matters of fact as such Purchaser may reasonably specify to enable such Purchaser to determine whether such purchase is so permitted. 

  
 -3- 

 Section 4.6. Sale of Bonds. Contemporaneously with the Closing, the Company shall
sell to each Purchaser and each Purchaser shall purchase the Bonds to be purchased by it at the Closing as specified in Schedule A. 

Section 4.7. Payment of Special Counsel Fees. Without limiting the provisions of Section 12.2, the Company shall have paid on
or before the Closing the reasonable fees, reasonable charges and reasonable disbursements of the Purchasers’ special counsel referred to in Section 4.4(c) to the extent reflected in a statement of such counsel rendered to the Company at
least one Business Day prior to the Closing. 
 Section 4.8. Private Placement Number. A Private Placement Number issued by
Standard & Poor’s CUSIP Service Bureau (in cooperation with the SVO) shall have been obtained for each series of Bonds. 

Section 4.9. Changes in Corporate Structure. The Company shall not have changed its jurisdiction of incorporation or organization,
as applicable, or been a party to any merger or consolidation or succeeded to all or any substantial part of the liabilities of any other entity, at any time following the date of the most recent financial statements referred to in
Schedule 5.5. 
 Section 4.10. Funding Instructions. At least three Business Days prior to the date of the Closing, each
Purchaser shall have received written instructions signed by a Responsible Officer on letterhead of the Company confirming the information specified in Section 3 including (a) the name and address of the transferee bank, (b) such
transferee bank’s ABA number and (c) the account name and number into which the purchase price for the Bonds is to be deposited. 

Section 4.11. Proceedings and Documents. All corporate and other proceedings in connection with the transactions contemplated by
this Agreement and all documents and instruments incident to such transactions shall be reasonably satisfactory to such Purchaser and its special counsel, and such Purchaser and its special counsel shall have received all such counterpart originals
or certified or other copies of such documents as such Purchaser or such special counsel may reasonably request. 
 Section 4.12.
Execution and Delivery and Filing and Recording of the Supplement. The Supplement shall have been duly executed and delivered by the Company, and the Company shall have filed, or delivered for recordation, the Supplement in all locations in
Pennsylvania (and financing statements in respect thereof shall have been filed, if necessary) in such manner and in such places as is required by law (and no other instruments are required to be filed) to establish, preserve, perfect and protect
the direct security interest and mortgage Lien of the Trust Estate created by the Indenture on all mortgaged and pledged property of the Company referred to in the Indenture as subject to the direct mortgage Lien thereof and the Company shall have
delivered satisfactory evidence of such filings, recording or delivery for recording. 

  
 -4- 

 Section 4.13. Regulatory Approvals. The issue and sale of the Bonds shall have been
duly authorized by an order of the Pennsylvania Public Utility Commission and such order shall be in full force and effect on the Closing Date and all appeal periods, if any, applicable to such order shall have expired. The Company shall deliver
satisfactory evidence that orders have been obtained approving the issuance of the Bonds from the Pennsylvania Public Utility Commission or that the Pennsylvania Public Utility Commission shall have waived jurisdiction thereof and such approval or
waiver shall not be contested or subject to review, or that the Pennsylvania Public Utility Commission does not have jurisdiction. 

SECTION 5. REPRESENTATIONS AND WARRANTIES OF THE
COMPANY. 
 The Company represents and warrants to each Purchaser that: 

Section 5.1. Organization; Power and Authority. The Company is a corporation duly organized, validly existing and subsisting under
the laws of the Commonwealth of Pennsylvania, and is duly qualified as a foreign corporation and is in good standing in each jurisdiction in which such qualification is required by law, other than those jurisdictions as to which the failure to be so
qualified or in good standing would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company has the corporate power and authority to own or hold under lease the properties it purports to own or
hold under lease, to transact the business it transacts and proposes to transact, to execute and deliver this Agreement, the Bonds and the Supplement (and had the corporate power and authority to execute and deliver the Indenture at the time of
execution and delivery thereof) and to perform the provisions of the Financing Agreements. 
 Section 5.2. Authorization, Etc.
Each Financing Agreement has been duly authorized by all necessary corporate action on the part of the Company, and each Financing Agreement (other than the Supplement and the Bonds) constitutes, and when the Supplement is executed and delivered by
the Company and the Trustee and when the Bonds are executed, issued and delivered by the Company, authenticated by the Trustee and paid for by the Purchasers, the Supplement and each Bond will constitute, a legal, valid and binding obligation of the
Company enforceable against the Company in accordance with its respective terms, except as such enforceability may be limited by (a) applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting the enforcement
of creditors’ rights generally and (b) general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law). 

Section 5.3. Disclosure. This Agreement and the documents, certificates or other writings delivered to the Purchasers by or on
behalf of the Company in connection with the transactions contemplated hereby, including the Private Placement Memorandum (including the documents incorporated therein by reference) dated September 12, 2013, and the financial statements listed
in Schedule 5.5 (collectively, the “Disclosure Documents”), taken as a whole, do not contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein not misleading in
light of the circumstances under which they were made. Since December 31, 2012, there has been no change in the financial condition, operations, business or properties of the Company or any of its Subsidiaries except changes that individually
or in the aggregate would not reasonably be expected to have a Material Adverse Effect. There is no fact known to management of the Company that, in the reasonable judgment of management of the Company, could be expected to have a Material Adverse
Effect that has not been set forth herein or in the other documents, certificates and other writings delivered to the Purchaser by the Company specifically for use in connection with the transactions contemplated hereby. 

  
 -5- 

 Section 5.4. Organization and Ownership of Shares of Subsidiaries.
(a) Schedule 5.4 contains a complete and correct list of the Company’s Subsidiaries, showing, as to each Subsidiary, the correct name thereof, the jurisdiction of its organization, and the percentage of shares of each class of its
capital stock or similar equity interests outstanding owned by the Company and each other Subsidiary. 
 (b) All of the outstanding shares of
capital stock or similar equity interests of each Subsidiary shown in Schedule 5.4 as being owned by the Company and its Subsidiaries have been validly issued, are fully paid and nonassessable and are owned by the Company or another Subsidiary
free and clear of any Lien. 
 (c) Each Subsidiary identified in Schedule 5.4 is duly incorporated and is validly subsisting as a
corporation under the laws of the Commonwealth of Pennsylvania, and is duly qualified as a foreign corporation or other legal entity and is in good standing in each jurisdiction in which such qualification is required by law, other than those
jurisdictions as to which the failure to be so qualified or in good standing could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Each such Subsidiary has the corporate or other power and authority
to own or hold under lease the properties it purports to own or hold under lease and to transact the business it transacts and proposes to transact. 

Section 5.5. Financial Statements; Material Liabilities. The Company has delivered to each Purchaser copies of the financial
statements of the Company and its Subsidiaries listed on Schedule 5.5. All of said financial statements (including in each case the related schedules and notes) fairly present in all material respects the consolidated financial position of the
Company and its Subsidiaries as of the respective dates specified in such financial statements and the consolidated results of their operations and cash flows for the respective periods so specified and have been prepared in accordance with GAAP
consistently applied throughout the periods involved except as set forth in the notes thereto (subject, in the case of any interim financial statements, to normal year-end adjustments). The Company does not
have any Material liabilities that are not disclosed on such financial statements or otherwise disclosed in the Disclosure Documents. 

Section 5.6. Compliance with Laws, Other Instruments, Etc. The execution, delivery and performance by the Company of each
Financing Agreement (including the prior execution and delivery of the Indenture), will not (a) contravene, result in any breach of, or constitute a default under, or result in the creation of any Lien, other than the Lien created under the
Indenture, in respect of any property of the Company or any Subsidiary under, any indenture, mortgage, deed of trust, loan, purchase or credit agreement, lease, corporate charter or by-laws, or any other Material agreement or instrument to which the
Company or any Subsidiary is bound or by which the Company or any Subsidiary or any of their respective properties may be bound or affected, (b) conflict with or result in a breach of any of the terms, conditions or provisions of any order,
judgment, decree, or ruling of any court, arbitrator or Governmental Authority applicable to the Company or any Subsidiary or (c) violate any provision of any statute or other rule or regulation of any Governmental Authority applicable to the
Company or any Subsidiary, except for any such default, breach, contravention or violation which would not reasonably be expected to have a Material Adverse Effect. 

  
 -6- 

 Section 5.7. Governmental Authorizations, Etc. No consent, approval or authorization
of, or registration, filing or declaration with, any Governmental Authority is required in connection with the execution, delivery or performance by the Company of this Agreement, the Bonds and the Supplement, other than approval of the Pennsylvania
Public Utility Commission, which has been obtained and is in full force and effect and final and is non-appealable. 
 Section 5.8.
Litigation; Observance of Statutes and Orders. (a) There are no actions, suits, investigations or proceedings pending or, to the knowledge of the Company, threatened against or affecting the Company or any Subsidiary or any property of the
Company or any Subsidiary in any court or before any arbitrator of any kind or before or by any Governmental Authority that, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect. 

(b) Neither the Company nor any Subsidiary is (i) in default under any term of any agreement or instrument to which it is a party or by
which it is bound, (ii) in violation of any order, judgment, decree or ruling of any court, arbitrator or Governmental Authority naming or referring to the Company or any Subsidiary or (iii) in violation of any applicable law, or, to the
knowledge of the Company, any ordinance, rule or regulation of any Governmental Authority (including, without limitation, Environmental Laws the USA Patriot Act or any of the other laws and regulations that are referred to in Section 5.16),
which default or violation, individually or in the aggregate, could reasonably be expected to have a Material Adverse Effect. 

Section 5.9. Taxes. The Company and its Subsidiaries have filed all income tax returns that are required to have been filed in any
jurisdiction, and have paid all taxes shown to be due and payable on such returns and all other taxes and assessments payable by them, to the extent such taxes and assessments have become due and payable and before they have become delinquent,
except for any taxes and assessments (i) the amount of which is not individually or in the aggregate Material or (ii) the amount, applicability or validity of which is currently being contested in good faith by appropriate proceedings and
with respect to which the Company or a Subsidiary, as the case may be, has established adequate reserves in accordance with GAAP. The charges, accruals, and reserves on the books of the Company and its Subsidiaries in respect of federal, state or
other taxes for all fiscal periods are adequate. The Federal income tax liabilities of the Company and its Subsidiaries have been finally determined (whether by reason of completed audits or the statute of limitations having run) for all fiscal
years up to and including the fiscal year ended December 31, 2011 and all amount owing is respect of such audit have been paid. 

  
 -7- 

 Section 5.10. Title to Property; Leases. The Company and its Subsidiaries have good
and sufficient title to their respective Material properties, including all such properties reflected in the most recent audited balance sheet referred to in Section 5.5 or purported to have been acquired by the Company or any Subsidiary after
said date (except as sold or otherwise disposed of in the ordinary course of business), in each case free and clear of Liens prohibited by this Agreement or the Indenture, except for those defects in title and Liens that, individually or in the
aggregate, would not have a Material Adverse Effect. All Material leases are valid and subsisting and are in full force and effect in all material respects. 

Section 5.11. Licenses, Permits, Etc. The Company and its Subsidiaries own or possess all licenses, permits, franchises,
certificates of conveyance and necessity, authorizations, patents, copyrights, proprietary software, service marks, trademarks and trade names, or rights thereto, that are Material, without known conflict with the rights of others, except for those
conflicts that, individually or in the aggregate, would not have a Material Adverse Effect. 
 Section 5.12. Compliance with
ERISA. (a) The Company and each ERISA Affiliate have operated and administered each Plan in compliance with all applicable laws except for such instances of noncompliance as have not resulted in and could not reasonably be expected to
result in a Material Adverse Effect. Neither the Company nor any ERISA Affiliate has incurred any liability pursuant to Title I or IV of ERISA or the penalty or excise tax provisions of the Code relating to employee benefit plans (as defined in
section 3 of ERISA), and no event, transaction or condition has occurred or exists that would reasonably be expected to result in the incurrence of any such liability by the Company or any ERISA Affiliate, or in the imposition of any Lien on
any of the rights, properties or assets of the Company or any ERISA Affiliate, in either case pursuant to Title I or IV of ERISA or to such penalty or excise tax provisions or to section 401(a)(29) or 412 of the Code or section 4068 of
ERISA, other than such liabilities or Liens as would not be individually or in the aggregate Material. 
 (b) The present value of the
aggregate benefit liabilities under each of the Plans subject to section 412 of the Code (other than Multiemployer Plans), determined as of January 1, 2013 based on such Plan’s actuarial assumptions as of that date for funding
purposes as documented in such Plan’s actuarial valuation reports dated September 2013 did not exceed the aggregate current value of the assets of such Plan allocable to such benefit liabilities by more than $5,000,000 in the case of any
single Plan and by more than $5,000,000 in the aggregate for all Plans. The term “benefit liabilities” has the meaning specified in section 4001 of ERISA and the terms “current value” and “present
value” have the meaning specified in section 3 of ERISA. 
 (c) The Company and its ERISA Affiliates have not incurred
withdrawal liabilities (and are not subject to contingent withdrawal liabilities) under section 4201 or 4204 of ERISA in respect of Multiemployer Plans that individually or in the aggregate are Material. 

(d) The expected postretirement benefit obligation (determined as of the last day of the Company’s most recently ended fiscal year in
accordance with Financial Accounting Standards Board Statement No. 106, without regard to liabilities attributable to continuation coverage mandated by section 4980B of the Code) of the Company and its Subsidiaries is not Material. 

  
 -8- 

 (e) The execution and delivery of this Agreement and the issuance and sale of the Bonds hereunder
will not involve any transaction that is subject to the prohibitions of section 406 of ERISA or in connection with which a tax could be imposed pursuant to section 4975(c)(1)(A)-(D) of the Code. The
representation by the Company to each Purchaser in the first sentence of this Section 5.12(e) is made in reliance upon and subject to the accuracy of such Purchaser’s representation in Section 6.2 as to the sources of the funds used
to pay the purchase price of the Bonds to be purchased by such Purchaser. 
 Section 5.13. Private Offering by the Company.
Neither the Company nor anyone acting on the Company’s behalf has offered the Bonds or any similar securities for sale to, or solicited any offer to buy any of the same from, or otherwise approached or negotiated in respect thereof with, any
Person other than the Purchasers and not more than twenty (20) other Institutional Investors, each of which has been offered the Bonds in connection with a private sale for investment. Neither the Company nor anyone acting on its behalf has
taken, or will take, any action that would subject the issuance or sale of the Bonds to the registration requirements of Section 5 of the Securities Act. 

Section 5.14. Use of Proceeds; Margin Regulations. The Company will apply the proceeds of the sale of the Bonds to repay existing
indebtedness and for general corporate purposes and in compliance with all laws referenced in Section 5.16. No part of the proceeds from the sale of the Bonds hereunder will be used, directly or indirectly, for the purpose of buying or carrying
any margin stock within the meaning of Regulation U of the Board of Governors of the Federal Reserve System (12 CFR 221), or for the purpose of buying or carrying or trading in any securities under such circumstances as to involve the Company
in a violation of Regulation X of said Board (12 CFR 224) or to involve any broker or dealer in a violation of Regulation T of said Board (12 CFR 220). Margin stock does not constitute more than 2% of the value of the consolidated assets of the
Company and its Subsidiaries and the Company does not have any present intention that margin stock will constitute more than 2% of the value of such assets. As used in this Section, the terms “margin stock” and “purpose of buying or
carrying” shall have the meanings assigned to them in said Regulation U. 
 Section 5.15. Existing Debt. Except as
described therein, Schedule 5.15(a) sets forth a complete and correct list of all outstanding Debt of the Company and its Subsidiaries as of June 30, 2013, since which date except as described therein there has been no Material change in the
amounts, interest rates, sinking funds, installment payments or maturities of the Debt of the Company or its Subsidiaries. Neither the Company nor any Subsidiary is in default and no waiver of default is currently in effect, in the payment of any
principal or interest on any Debt of the Company or any Subsidiary and no event or condition exists with respect to any Debt of the Company or any Subsidiary, the outstanding principal amount of which exceeds $5,000,000 that would permit (or that
with notice or the lapse of time, or both, would permit) one or more Persons to cause such Debt to become due and payable before its stated maturity or before its regularly scheduled dates of payment. 

(b) Without limiting the representation in Section 5.6, the Company is not a party to, or otherwise subject to any provision contained in,
any instrument evidencing Debt of the Company or any Subsidiary, any agreement relating thereto or any other agreement (including, but not limited to, its charter or other organizational document) which limits the amount of, or otherwise imposes
restrictions on the incurring of, Debt evidenced by the Bonds, except as specifically indicated in Schedule 5.15(b). 

  
 -9- 

 Section 5.16. Foreign Assets Control Regulations, Etc. (a) Neither the Company
nor any Controlled Entity is (i) a Person whose name appears on the list of Specially Designated Nationals and Blocked Persons published by the Office of Foreign Assets Control, U.S. Department of Treasury (“OFAC”) or a Person
that is otherwise subject to an OFAC Sanctions Program (an “OFAC Listed Person”) or (ii) a department, agency or instrumentality of, or is otherwise controlled by or acting on behalf of, directly or indirectly, (x) any
OFAC Listed Person or (y) any Person, entity, organization, foreign country or regime that is subject to any OFAC Sanctions Program (each OFAC Listed Person and each other Person, entity, organization and government of a country described in
clause (ii), a “Blocked Person”). 
 (b) No part of the proceeds from the sale of the Bonds hereunder constitutes or will
constitute funds obtained on behalf of any Blocked Person or will otherwise be used, directly by the Company or indirectly through any Controlled Entity, in connection with any investment in, or any transactions or dealings with, any Blocked Person
or for investment in the Iranian energy sector (as defined in Section 201 (1) of CISADA). 
 (c) To the Company’s
knowledge after making due inquiry, neither the Company nor any Controlled Entity (i) is under investigation by any Governmental Authority for, or has been charged with, or convicted of, money laundering, drug trafficking, terrorist-related
activities or other money laundering predicate crimes under any applicable law (collectively, “Anti-Money Laundering Laws”), (ii) has been assessed civil penalties under any Anti-Money Laundering Laws or (iii) has had any
of its funds seized or forfeited in an action under any Anti-Money Laundering Laws. The Company has taken reasonable measures appropriate to the circumstances (in any event as required by applicable law) to ensure that the Company and each
Controlled Entity is and will continue to be in compliance with all applicable current and future Anti-Money Laundering Laws. 
 (d) No part
of the proceeds from the sale of the Bonds hereunder will be used, directly or indirectly, for any improper payments to any governmental official or employee, political party, official of a political party, candidate for political office, official
of any public international organization or anyone else acting in an official capacity, in order to obtain, retain or direct business or obtain any improper advantage. The Company has taken reasonable measures appropriate to the circumstances (in
any event as required by applicable law) to ensure that the Company and each Controlled Entity is and will continue to be in compliance with all applicable current and future anti-corruption laws and regulations. 

Section 5.17. Status under Certain Statutes. Neither the Company nor any Subsidiary is subject to regulation under the Investment
Company Act of 1940, as amended, the Public Utility Holding Company Act of 2005, as amended, the ICC Termination Act of 1995, as amended, or subject to rate regulation under the Federal Power Act, as amended. 

  
 -10- 

 Section 5.18. Environmental Matters. Neither the Company nor any Subsidiary has
knowledge of any claim or has received any notice of any claim, and no proceeding has been instituted of which it has received notice, raising any claim against the Company or any of its Subsidiaries or any of their respective real properties now or
formerly owned, leased or operated by any of them, or other assets, alleging damage to the environment or any violation of any Environmental Laws, except, in each case, such as could not reasonably be expected to result in a Material Adverse Effect.
Except as otherwise disclosed to the Purchaser in writing: 
 (a) neither the Company nor any Subsidiary has knowledge of any
facts which would give rise to any claim, public or private, for violation of Environmental Laws or damage to the environment emanating from, occurring on or in any way related to real properties or to other assets now or formerly owned, leased or
operated by any of them or their use, except, in each case, such as could not reasonably be expected to result in a Material Adverse Effect; 

(b) neither the Company nor any of its Subsidiaries has stored any Hazardous Materials on real properties now or formerly
owned, leased or operated by any of them or has disposed of any Hazardous Materials in each case in a manner contrary to any Environmental Laws and in any manner that could reasonably be expected to result in a Material Adverse Effect; and 

(c) all buildings on all real properties now owned, leased or operated by the Company or any of its Subsidiaries are in compliance with
applicable Environmental Laws, except where failure to comply could not reasonably be expected to result in a Material Adverse Effect. 

Section 5.19. Lien of Indenture. The Indenture (and for avoidance of doubt including the Supplement) constitutes a direct and
valid Lien upon the Trust Estate, subject only to the exceptions referred to in the Indenture and Permitted Liens, and will create a similar Lien upon all properties and assets acquired by the Company after the date hereof which are required to be
subjected to the Lien of the Indenture, when acquired by the Company, subject only to the exceptions referred to in the Indenture and Permitted Liens, and subject, further, as to real property interests, to the recordation of a supplement to the
Indenture describing such after-acquired property; the descriptions of all such properties and assets contained in the granting clauses of the Indenture are correct and adequate for the purposes of the Indenture; the Indenture has been duly recorded
as a mortgage and deed of trust of real estate, and any required filings with respect to personal property and fixtures subject to the Lien of the Indenture have been duly made in each place in which such recording or filing is required to protect,
preserve and perfect the Lien of the Indenture; and all taxes and recording and filing fees required to be paid with respect to the execution, recording or filing of the Indenture, the filing of financing statements related thereto and similar
documents and the issuance of the Bonds have been paid. 
 Section 5.20. Filings. No action, including any filings, registration
or notice, is necessary or advisable in Pennsylvania or any other jurisdictions to ensure the legality, validity and enforceability of the Financing Agreements, except such action as has been previously taken, which action remains in full force and
effect. No action, including any filing, registration or notice, is necessary or advisable in Pennsylvania or any other jurisdiction to establish or protect for the benefit of the Trustee and the holders of Bonds, the security interest and Liens
purported to be created under the Indenture and the priority and perfection therof and the other Financing Agreements, except such action as has been previously taken, which action remains in full force and effect. 

  
 -11- 

 SECTION 6. REPRESENTATIONS OF THE
PURCHASERS. 
 Section 6.1. Purchase for Investment. Each Purchaser severally represents that it is purchasing the
Bonds for its own account or for one or more separate accounts maintained by such Purchaser or for the account of one or more pension or trust funds and not with a view to the distribution thereof, provided that the disposition of such
Purchaser’s or their property shall at all times be within such Purchaser’s or their control. Each Purchaser understands that the Bonds have not been registered under the Securities Act and may be resold only if registered pursuant to the
provisions of the Securities Act or if an exemption from registration is available, except under circumstances where neither such registration nor such an exemption is required by law, and that the Company is not required to register the Bonds. 

Section 6.2. Source of Funds. Each Purchaser severally represents that at least one of the following statements is an accurate
representation as to each source of funds (a “Source”) to be used by such Purchaser to pay the purchase price of the Bonds to be purchased by such Purchaser hereunder: 

(a) the Source is an “insurance company general account” (as the term is defined in the United States Department of
Labor’s Prohibited Transaction Exemption (“PTE”) 95-60) in respect of which the reserves and liabilities (as defined by the annual statement for life insurance companies approved by the
NAIC (the “NAIC Annual Statement”)) for the general account contract(s) held by or on behalf of any employee benefit plan together with the amount of the reserves and liabilities for the general account contract(s) held by or on
behalf of any other employee benefit plans maintained by the same employer (or affiliate thereof as defined in PTE 95-60) or by the same employee organization in the general account do not exceed 10% of the
total reserves and liabilities of the general account (exclusive of separate account liabilities) plus surplus as set forth in the NAIC Annual Statement filed with such Purchaser’s state of domicile; or 

(b) the Source is a separate account that is maintained solely in connection with such Purchaser’s fixed contractual
obligations under which the amounts payable, or credited, to any employee benefit plan (or its related trust) that has any interest in such separate account (or to any participant or beneficiary of such plan (including any annuitant)) are not
affected in any manner by the investment performance of the separate account; or 
 (c) the Source is either (i) an
insurance company pooled separate account, within the meaning of PTE 90-1 or (ii) a bank collective investment fund, within the meaning of the PTE 91-38 and, except
as disclosed by such Purchaser to the Company in writing pursuant to this clause (c), no employee benefit plan or group of plans maintained by the same employer or employee organization beneficially owns more than 10% of all assets allocated to such
pooled separate account or collective investment fund; or 

  
 -12- 

 (d) the Source constitutes assets of an “investment fund” (within the
meaning of Part VI of PTE 84-14 (the “QPAM Exemption”)) managed by a “qualified professional asset manager” or “QPAM” (within the meaning of Part VI of the QPAM Exemption),
no employee benefit plan’s assets that are managed by the QPAM in such investment fund, when combined with the assets of all other employee benefit plans established or maintained by the same employer or by an affiliate (within the meaning of
Part VI(c)(1) of the QPAM Exemption) of such employer or by the same employee organization and managed by such QPAM, represent more than 20% of the total client assets managed by such QPAM, the conditions of Part I(c) and (g) of the QPAM
Exemption are satisfied, neither the QPAM nor a person controlling or controlled by the QPAM maintains an ownership interest in the Company that would cause the QPAM and the Company to be “related” within the meaning of Part VI(h) of the
QPAM Exemption and (i) the identity of such QPAM and (ii) the names of any employee benefit plans whose assets in the investment fund, when combined with the assets of all other employee benefit plans established or maintained by the same
employer or by an affiliate (within the meaning of Part VI(c)(1) of the QPAM Exemption) of such employer or by the same employee organization, represent 10% or more of the assets of such investment fund, have been disclosed to the Company in writing
pursuant to this clause (d);or 
 (e) the Source constitutes assets of a “plan(s)” (within the meaning of
Part IV(h) of PTE 96-23 (the “INHAM Exemption”)) managed by an “in-house asset manager” or “INHAM” (within the meaning of Part
IV(a) of the INHAM Exemption), the conditions of Part I(a), (g) and (h) of the INHAM Exemption are satisfied, neither the INHAM nor a person controlling or controlled by the INHAM (applying the definition of “control” in Part
IV(d)(3) of the INHAM Exemption) owns a 10% or more interest in the Company and (i) the identity of such INHAM and (ii) the name(s) of the employee benefit plan(s) whose assets constitute the Source have been disclosed to the Company in
writing pursuant to this clause (e); or 
 (f) the Source is a governmental plan; or 

(g) the Source is one or more employee benefit plans, or a separate account or trust fund comprised of one or more employee
benefit plans, each of which has been identified to the Company in writing pursuant to this clause (g); or 
 (h) the Source
does not include assets of any employee benefit plan, other than a plan exempt from the coverage of ERISA. 
 As used in this Section 6.2, the terms
“employee benefit plan,” “governmental plan,” and “separate account” shall have the respective meanings assigned to such terms in section 3 of ERISA. 

  
 -13- 

 SECTION 7. INFORMATION AS TO
COMPANY. 
 Section 7.1. Financial and Business Information. The Company shall deliver to each holder of Bonds
that is an Institutional Investor: 
 (a) Quarterly Statements — within 60 days after the end of each quarterly
fiscal period in each fiscal year of the Company (other than the last quarterly fiscal period of each such fiscal year), duplicate copies of: 

(i) a consolidated balance sheet of the Company and its Subsidiaries as at the end of such quarter, and 

(ii) consolidated statements of income, changes in shareholders’ equity and cash flows of the Company and its
Subsidiaries, for such quarter and (in the case of the second and third quarters) for the portion of the fiscal year ending with such quarter, 

setting forth in each case in comparative form the figures for the corresponding periods in the previous fiscal year, all in reasonable detail,
prepared in accordance with GAAP applicable to quarterly financial statements generally, and certified by a Senior Financial Officer as fairly presenting, in all material respects, the financial position of the companies being reported on and their
results of operations and cash flows, subject to changes resulting from year-end adjustments, provided that the delivery within the time period specified above of the Company’s said financial
statements, prepared in accordance with the requirements therefor and filed with the Municipal Securities Rulemaking Board on the Electronic Municipal Market Access (“EMMA”) database shall be deemed to satisfy the requirements of
this Section 7.1(a); 
 (b) Annual Statements — within 120 days after the end of each fiscal year of the
Company, duplicate copies of: 
 (i) a consolidated balance sheet of the Company and its Subsidiaries, as at the end of such
year, and 
 (ii) consolidated statements of income, changes in shareholders’ equity and cash flows of the Company and
its Subsidiaries for such year, 
 setting forth in each case in comparative form the figures for the previous fiscal year, all in reasonable
detail, prepared in accordance with GAAP, and accompanied by an opinion thereon of independent public accountants of recognized national standing, which opinion shall state that such financial statements present fairly, in all material respects, the
financial position of the companies being reported upon and their results of operations and cash flows and have been prepared in conformity with GAAP, and that the examination of such accountants in connection with such financial statements has been
made in accordance with generally accepted auditing standards, and that such audit provides a reasonable basis for such opinion in the circumstances, provided that the delivery within the time period specified above of the Company’s said
financial statements, prepared in accordance with the requirements therefor and filed with the Municipal Securities Rulemaking Board on the EMMA database shall be deemed to satisfy the requirements of this Section 7.1(b); 

  
 -14- 

 (c) SEC and Other Reports — promptly upon their becoming available,
one copy of (i) each financial statement, report, notice or proxy statement sent by the Company or any Subsidiary to its public securities holders generally, and (ii) each regular or periodic report, each registration statement that shall
have become effective (without exhibits except as expressly requested by such holder), and each final prospectus and all amendments thereto filed by the Company or any Subsidiary with the SEC, provided that the delivery within the time period
specified above of the Company’s said financial statements, prepared in accordance with the requirements therefor and filed with the Municipal Securities Rulemaking Board on the EMMA database shall be deemed to satisfy the requirements of this
Section 7.1(c); 
 (d) Notice of Default or Event of Default — promptly, and in any event within five days
after a Responsible Officer becomes aware of the existence of any Default or Event of Default, a written notice specifying the nature and period of existence thereof and what action the Company is taking or proposes to take with respect thereto;

 (e) ERISA Matters — promptly, and in any event within five days after a Responsible Officer becomes aware of
any of the following, a written notice setting forth the nature thereof and the action, if any, that the Company or an ERISA Affiliate proposes to take with respect thereto: 

(i) with respect to any Plan (other than any Multiemployer Plan) that is subject to Title IV of ERISA, any reportable
event, as defined in section 4043(c) of ERISA and the regulations thereunder, for which notice thereof has not been waived pursuant to such regulations as in effect on the date hereof and on the date of the Closing; or 

(ii) the taking by the PBGC of steps to institute, or the threatening by the PBGC of the institution of, proceedings under
section 4042 of ERISA for the termination of, or the appointment of a trustee to administer, any such Plan, or the receipt by the Company or any ERISA Affiliate of a notice from a Multiemployer Plan that such action has been taken by the PBGC
with respect to such Multiemployer Plan; or 
 (iii) any event, transaction or condition that could result in the incurrence
of any liability by the Company or any ERISA Affiliate pursuant to Title I or IV of ERISA or the penalty or excise tax provisions of the Code relating to employee benefit plans, or in the imposition of any Lien on any of the rights, properties or
assets of the Company or any ERISA Affiliate pursuant to Title I or IV of ERISA or such penalty or excise tax provisions, if such liability or Lien, taken together with any other such liabilities or Liens then existing, would reasonably be expected
to have a Material Adverse Effect; 

  
 -15- 

 (f) Notices from Governmental Authority — promptly, and in any event
within 30 days of receipt thereof, copies of any notice to the Company or any Subsidiary from any federal or state Governmental Authority relating to any order, ruling, statute or other law or regulation that could reasonably be expected to have a
Material Adverse Effect; 
 (g) Requested Information — with reasonable promptness, following the receipt by the
Company of a written request by such holder of Bonds, the names and contact information of holders of the outstanding bonds issued under the Indenture (i.e. the bonds in which the Company or a trustee is required to keep in a register and that are
not publicly traded) of which the Company has knowledge and the principal amount of the outstanding bonds issued under the Indenture owed to each holder (unless disclosure of such names, contact information or holdings is prohibited by law), and
such data and information relating to the business, operations, affairs, financial condition, assets or properties of the Company or any of its Subsidiaries or relating to the ability of the Company to perform its obligations under any Financing
Agreement as from time to time may be reasonably requested by such holder of Bonds; and 
 (h) Deliveries to Trustee —
promptly, and in any event within five days after delivery to the Trustee, a copy of any deliveries made by the Company to the Trustee, including without limitation the annual report delivered to the Trustee pursuant to Article VIII, Section 12
of the Indenture. 
 Section 7.2 Officer’s Certificate. Each set of financial statements delivered to a holder of Bonds
pursuant to Section 7.1(a) or Section 7.1(b) shall be accompanied by a certificate of a Senior Financial Officer (which, in the case of financial statements filed with the Municipal Securities Rulemaking Board on the EMMA database, shall
be by separate concurrent delivery of such certificate to each holder of Bonds) setting forth a statement that such Senior Financial Officer has reviewed the relevant terms hereof and of the Indenture and has made, or caused to be made, under his or
her supervision, a review of the transactions and conditions of the Company and its Subsidiaries from the beginning of the quarterly or annual period covered by the statements then being furnished to the date of the certificate and that such review
shall not have disclosed the existence during such period of any condition or event that constitutes a Default or an Event of Default or, if any such condition or event existed or exists (including, without limitation, any such event or condition
resulting from the failure of the Company or any Subsidiary to comply with any Environmental Law), specifying the nature and period of existence thereof and what action the Company shall have taken or proposes to take with respect thereto. 

  
 -16- 

 Section 7.3. Visitation. The Company shall permit the representatives of each holder
of Bonds that is an Institutional Investor: 
 (a) No Default — if no Default or Event of Default then exists, at
the expense of such holder and upon reasonable prior notice to the Company, to visit the principal executive office of the Company, to discuss the affairs, finances and accounts of the Company and its Subsidiaries with the Company’s officers,
and, with the consent of the Company (which consent will not be unreasonably withheld), to visit the other offices and properties of the Company and each Subsidiary, all at such reasonable times during normal business hours and as often as may be
reasonably requested in writing; and 
 (b) Default — if a Default or Event of Default then exists, at the
expense of the Company to visit and inspect any of the offices or properties of the Company or any Subsidiary, to examine all their respective books of account, records, reports and other papers, to make copies and extracts therefrom, and to discuss
their respective affairs, finances and accounts with their respective officers and independent public accountants (and by this provision the Company authorizes said accountants to discuss the affairs, finances and accounts of the Company and its
Subsidiaries), all at such reasonable times and as often as may be requested. 
 SECTION 8. PURCHASE OF
BONDS 
 The Company will not and will not permit any Affiliate to purchase, redeem, prepay or otherwise acquire, directly or
indirectly, any of the outstanding Bonds except (a) upon the payment or prepayment of the Bonds in accordance with the terms of this Agreement and the Bonds or (b) pursuant to a written offer to purchase any outstanding Bonds made by the
Company or an Affiliate pro rata to the holders of the Bonds upon the same terms and conditions. Any such offer shall provide each holder with sufficient information to enable it to make an informed decision with respect to such offer, and shall
remain open for at least 15 Business Days. If the holders of more than 10% of the principal amount of the Bonds then outstanding accept such offer, the Company shall promptly notify the remaining holders of such fact and the expiration date for the
acceptance by holders of Bonds of such offer shall be extended by the number of days necessary to give each such remaining holder at least 10 Business Days from its receipt of such notice to accept such offer. The Company will promptly cancel all
Bonds acquired by it or any Affiliate pursuant to any payment, prepayment or purchase of Bonds pursuant to any provision of this Agreement and no Bonds may be issued in substitution or exchange for any such Bonds. 

SECTION 9. AFFIRMATIVE COVENANTS. 

The Company covenants that so long as any of the Bonds are outstanding: 

Section 9.1. Compliance with Law. Without limiting Section 10.4, the Company will, and will cause each of its Subsidiaries to,
comply with all laws, ordinances or governmental rules or regulations to which each of them is subject, including, without limitation, ERISA, Environmental Laws, the USA Patriot Act and the other laws and regulations that are referred to in
Section 5.16, and will obtain and maintain in effect all licenses, certificates, permits, franchises and other governmental authorizations necessary to the ownership of their respective properties or to the conduct of their respective
businesses, in each case to the extent necessary to ensure that non-compliance with such laws, ordinances or governmental rules or regulations or failures to obtain or maintain in effect such licenses,
certificates, permits, franchises and other governmental authorizations could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. 

  
 -17- 

 Section 9.2. Insurance. The Company will cause each of its Subsidiaries to maintain,
with financially sound and reputable insurers, insurance with respect to their respective properties and businesses against such casualties and contingencies, of such types, on such terms and in such amounts (including deductibles, co-insurance and
self-insurance, if adequate reserves are maintained with respect thereto) as is customary in the case of entities of established reputations engaged in the same or a similar business and similarly situated. 

Section 9.3. Maintenance of Properties. The Company will cause each of its Subsidiaries to maintain and keep, or cause to be
maintained and kept, their respective properties in good repair, working order and condition (other than ordinary wear and tear), so that the business carried on in connection therewith may be properly conducted at all times, provided that
this Section shall not prevent any Subsidiary from discontinuing the operation and the maintenance of any of its properties if such discontinuance is desirable in the conduct of its business and the Company and such Subsidiary has concluded that
such discontinuance would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. 

Section 9.4. Payment of Taxes. The Company will cause each of its Subsidiaries to file all income tax or similar tax returns
required to be filed in any jurisdiction and to pay and discharge all taxes shown to be due and payable on such returns and all other taxes, assessments, governmental charges, or levies payable by any of them, to the extent the same have become due
and payable and before they have become delinquent, provided that any Subsidiary does not need to pay any such tax, assessment, charge or levy if (a) the amount, applicability or validity thereof is contested by the Company or such Subsidiary
on a timely basis in good faith and in appropriate proceedings, and the Subsidiary has established adequate reserves therefor in accordance with GAAP on the books of such Subsidiary or (b) the nonpayment of all such taxes, assessments, charges
and levies in the aggregate would not reasonably be expected to have a Material Adverse Effect. 
 Section 9.5. Corporate Existence,
Etc. The Company will at all times preserve and keep in full force and effect the corporate existence of each of its Subsidiaries (unless merged into the Company or a wholly-owned Subsidiary) and all
rights and franchises of its Subsidiaries unless, in the good faith judgment of the Company or such Subsidiary, the termination of or failure to preserve and keep in full force and effect such corporate existence, right or franchise would not,
individually or in the aggregate, have a Material Adverse Effect. 
 Section 9.6. Books and Records. The Company will, and will
cause each of its Subsidiaries to, maintain proper books of record and account in conformity with GAAP and all applicable requirements of any Governmental Authority having legal or regulatory jurisdiction over the Company or such Subsidiary. 

  
 -18- 

 SECTION 10. NEGATIVE COVENANTS. 

The Company covenants that so long as any of the Bonds are outstanding: 

Section 10.1. Transactions with Affiliates. The Company will not and will not permit any Subsidiary to enter into directly or
indirectly any Material transaction or Material group of related transactions (including without limitation the purchase, lease, sale or exchange of properties of any kind or the rendering of any service) with any Affiliate (other than the Company
or another Subsidiary), except pursuant to the reasonable requirements of the Company’s or such Subsidiary’s business. 

Section 10.2. Merger, Consolidation, Etc. The Company will not consolidate with or merge with any other Person or convey, transfer
or lease all or substantially all of its assets in a single transaction or series of transactions to any Person unless: 

(a) the successor formed by such consolidation or the survivor of such merger or the Person that acquires by conveyance,
transfer or lease all or substantially all of the assets of the Company as an entirety, as the case may be, shall be a solvent corporation or limited liability company organized and existing under the laws of the United States or any State thereof
(including the District of Columbia), and, if the Company is not such corporation or limited liability company, such corporation or limited liability company shall have executed and delivered to each holder of any Bonds its assumption of the due and
punctual performance and observance of each covenant and condition of the Financing Agreements (pursuant to such agreements and instruments as shall be reasonably satisfactory to the Required Holders), and the Company shall have caused to be
delivered to each holder of Bonds an opinion of nationally recognized independent counsel, to the effect that all agreements or instruments effecting such assumption are enforceable in accordance with their terms and comply with the terms hereof;
and 
 (b) immediately before and immediately after giving effect to such transaction, no Default or Event of Default shall
have occurred and be continuing. 
 No such conveyance, transfer or lease of substantially all of the assets of the Company shall have the effect of
releasing the Company or any successor corporation or limited liability company that shall theretofore have become such in the manner prescribed in this Section 10.2 from its liability under the Financing Agreements. 

Section 10.3. Line of Business. The Company will not engage in any business if, as a result, the general nature of the business in
which the Company and its Subsidiaries, taken as a whole, would then be engaged would be substantially changed from the general nature of the business in which the Company and its Subsidiaries, taken as whole, is engaged on the date of this
Agreement. 
 Section 10.4. Terrorism Sanctions Regulations. The Company will not and will not permit any Controlled Entity to
(a) become a Blocked Person or (b) have any investments in or engage in any dealings or transactions with any Blocked Person except in accordance with applicable law and in a manner where such investments, transactions or dealings would
not cause the purchase, holding or receipt of any payment or exercise of any rights in respect of any Bond by the holder thereof to be in violation of any laws or regulations administered by OFAC. 

  
 -19- 

 SECTION 11. PAYMENTS ON BONDS. 

Section 11.1. Home Office Payment. So long as any Purchaser or its nominee shall be the holder of any Bond, and notwithstanding
anything contained in the Indenture or in such Bond to the contrary, the Company will pay, or cause to be paid by a paying agent, a trustee or other similar party, all sums becoming due on such Bond for principal,
Make-Whole Amount or premium, if any, and interest by the method and at the address specified for such purpose below such Purchaser’s name in Schedule A, or by such other method or at such other
address as such Purchaser shall have from time to time specified to the Company in writing for such purpose, without the presentation or surrender of such Bond or the making of any notation thereon, except that upon written request of the Company or
any paying agent made concurrently with or reasonably promptly after payment or prepayment in full of any Bond, such Purchaser shall surrender such Bond for cancellation, reasonably promptly after any such request, to the Company at its principal
executive office or at the place of payment most recently designated by the Company pursuant to Article II of the Indenture. Prior to any sale or other disposition of any Bond held by a Purchaser or its nominee, such Purchaser will, at its election,
either endorse thereon the amount of principal paid thereon and the last date to which interest has been paid thereon or surrender such Bond to the Company in exchange for a new Bond or Bonds pursuant to Article II of the Indenture. The Company will
afford the benefits of this Section 11.1 to any Institutional Investor that is the direct or indirect transferee of any Bond purchased by a Purchaser under this Agreement and that has made the same agreement relating to such Bond as the
Purchasers have made in this Section 11.1. 
 SECTION 12. REGISTRATION; EXCHANGE;
EXPENSES, ETC. 
 Section 12.1. Registration of Bonds. The Company shall cause the Trustee to keep
a register for the registration and registration of transfers of Bonds in accordance with Article XIII, Section 9 of the Indenture. 

Section 12.2. Transaction Expenses. Whether or not the transactions contemplated hereby are consummated, the Company will pay all
reasonable costs and expenses (including reasonable attorneys’ fees of a special counsel and, if reasonably required by the Required Holders, local or other counsel) incurred by the Purchasers and each other holder of a Bond in connection with
such transactions and in connection with any amendments, waivers or consents under or in respect of any Financing Agreement (whether or not such amendment, waiver or consent becomes effective), including, without limitation: (a) the costs and
expenses incurred in enforcing or defending (or determining whether or how to enforce or defend) any rights under any Financing Agreement or in responding to any subpoena or other legal process or informal investigative demand issued in connection
with any Financing Agreement, or by reason of being a holder of any Bond, (b) the costs and expenses, including financial advisors’ fees, incurred in connection with the insolvency or bankruptcy of the Company or any Subsidiary or in
connection with any work-out or restructuring of the transactions contemplated by any Financing Agreement and (c) the costs and expenses incurred in connection with the initial filing of any Financing
Agreement and all related documents and financial information with the SVO, provided that such costs and expenses under this clause (c) shall not exceed $5,000 for the Bonds. The Company will pay, and will save each Purchaser and each other
holder of a Bond harmless from, all claims in respect of any fees, costs or expenses if any, of brokers and finders (other than those, if any, retained by a Purchaser or other holder in connection with its purchase of the Bonds). 

  
 -20- 

 Section 12.3. Survival. The obligations of the Company under this Section 12
will survive the payment or transfer of any Bond, the enforcement, amendment or waiver of any provision of any Financing Agreement, and the termination of any Financing Agreement. 

SECTION 13. SURVIVAL OF REPRESENTATIONS AND WARRANTIES;
ENTIRE AGREEMENT. 
 All representations and warranties contained herein shall survive the execution and
delivery of this Agreement, the purchase or transfer by any Purchaser of any Bond or portion thereof or interest therein and the payment of any Bond, and may be relied upon by any subsequent holder of a Bond, regardless of any investigation made at
any time by or on behalf of such Purchaser or any other holder of a Bond. All statements contained in any certificate or other instrument delivered by or on behalf of the Company pursuant to this Agreement shall be deemed representations and
warranties of the Company under this Agreement. Subject to the preceding sentence, the Financing Agreements embody the entire agreement and understanding between each Purchaser and the Company and supersede all prior agreements and understandings
relating to the subject matter hereof. 
 SECTION 14. AMENDMENT AND WAIVER. 

Section 14.1. Requirements. This Agreement and the Bonds may be amended, and the observance of any term hereof or of the Bonds may
be waived (either retroactively or prospectively), with (and only with) the written consent of the Company and the Required Holders, except that (i) no amendment or waiver of any of the provisions of Section 1, 2, 3, 4, 5, 6 or 19 hereof,
or any defined term, will be effective as to any holder of Bonds unless consented to by such holder of Bonds in writing, and (ii) no such amendment or waiver may, without the written consent of all of the holders of Bonds at the time
outstanding affected thereby, (A) subject to the provisions of the Indenture relating to acceleration, change the amount or time of any prepayment or payment of principal of, or reduce the rate or change the time of payment or method of
computation of interest (if such change results in a decrease in the interest rate) or of the Make-Whole Amount on, the Bonds, (B) change the percentage of the principal amount of the Bonds the holders of which are required to consent to any
such amendment or waiver, or (C) amend any of Sections 8, 14 or 18. 
 Section 14.2. Solicitation of Holders of Bonds.

 (a) Solicitation. The Company will provide each holder of the Bonds (irrespective of the amount of Bonds then owned by it) with
sufficient information, sufficiently far in advance of the date a decision is required, to enable such holder to make an informed and considered decision with respect to any proposed amendment, waiver or consent in respect of any of the provisions
hereof or of the Bonds. The Company will deliver executed or true and correct copies of each amendment, waiver or consent effected pursuant to the provisions of this Section 14 to each holder of outstanding Bonds promptly following the date on
which it is executed and delivered by, or receives the consent or approval of, the requisite holders of Bonds. 

  
 -21- 

 (b) Payment. The Company will not directly or indirectly pay or cause to be paid any
remuneration, whether by way of supplemental or additional interest, fee or otherwise (other than legal fees or other related expenses), or grant any security or provide other credit support, to any holder of Bonds as consideration for or as an
inducement to the entering into by any holder of Bonds or any waiver or amendment of any of the terms and provisions hereof unless such remuneration is concurrently paid, or security is concurrently granted or other credit support concurrently
provided, on the same terms, ratably to each holder of Bonds then outstanding even if such holder did not consent to such waiver or amendment. 

(c) Consent in Contemplation of Transfer. Any consent made pursuant to this Section 14 by the holder of any Bond that has
transferred or has agreed to transfer such Bond to the Company, any Subsidiary or any Affiliate of the Company and has provided or has agreed to provide such written consent as a condition to such transfer shall be void and of no force or effect
except solely as to such holder, and any amendments effected or waivers granted or to be effected or granted that would not have been or would not be so effected or granted but for such consent (and the consents of all other holders of Bonds that
were acquired under the same or similar conditions) shall be void and of no force or effect except solely as to such transferring holder. 

Section 14.3. Binding Effect, Etc. Any amendment or waiver consented to as provided in this Section 14 applies equally to all
holders of Bonds and is binding upon them and upon each future holder of any Bond and upon the Company without regard to whether such Bond has been marked to indicate such amendment or waiver. No such amendment or waiver will extend to or affect any
obligation, covenant, agreement, Default or Event of Default not expressly amended or waived or impair any right consequent thereon. No course of dealing between the Company and the holder of any Bond nor any delay in exercising any rights hereunder
or under any Bond shall operate as a waiver of any rights of any holder of such Bond. As used herein, the term “this Agreement” and references thereto shall mean this Agreement as it may from time to time be amended or supplemented. 

Section 14.4. Bonds Held by Company, Etc. Solely for the purpose of determining whether the holders of the requisite percentage of
the aggregate principal amount of Bonds then outstanding approved or consented to any amendment, waiver or consent to be given under this Agreement or the Bonds, or have directed the taking of any action provided herein or in the Bonds to be taken
upon the direction of the holders of a specified percentage of the aggregate principal amount of Bonds then outstanding, Bonds directly or indirectly owned by the Company or any of its Affiliates shall be deemed not to be outstanding. 

  
 -22- 

 SECTION 15. NOTICES. 

All notices and communications provided for hereunder shall be in writing and sent (a) by telecopy if the sender on the same day sends a
confirming copy of such notice by a recognized overnight delivery service (charges prepaid), or (b) by registered or certified mail with return receipt requested (postage prepaid), or (c) by a recognized overnight delivery service (with
charges prepaid). Any such notice must be sent: 
 (i) if to any Purchaser or its nominee, to such Purchaser or nominee at
the address specified for such communications in Schedule A, or at such other address as such Purchaser or nominee shall have specified to the Company in writing, 

(ii) if to any other holder of any Bond, to such holder at such address as such other holder shall have specified to the
Company in writing, or 
 (iii) if to the Company, to the Company at its address set forth at the beginning hereof to the
attention of 762 West Lancaster Avenue, Bryn Mawr, Pennsylvania 19010-3489, or at such other address as the Company shall have specified to the holder of each Bond in writing, or 

(iv) if to the Trustee, to The Bank of New York Mellon Trust Company, N.A., as Trustee, 1735 Market Street, 6th Floor, AIM
No.: 193-0650, Philadelphia, PA 19103, or at such other address as the Trustee shall have specified to the Company and each other party hereto in writing. 

Notices under this Section 15 will be deemed given only when actually received. 

SECTION 16. INDEMNIFICATION. 

The Company hereby agrees to indemnify and hold the Purchasers harmless from, against and in respect of any and all loss, liability and expense
(including reasonable attorneys’ fees) arising from any misrepresentation or nonfulfillment of any undertaking on the part of the Company under this Agreement. The indemnification obligations of the Company under this Section 16 shall
survive the execution and delivery of this Agreement, the delivery of the Bonds to the Purchasers and the consummation of the transactions contemplated herein. 

SECTION 17. REPRODUCTION OF DOCUMENTS. 

This Agreement and all documents relating thereto, including, without limitation, (a) consents, waivers and modifications that may
hereafter be executed, (b) documents received by any Purchaser at the Closing (except the Bonds themselves), and (c) financial statements, certificates and other information previously or hereafter furnished to any Purchaser, may be
reproduced by such Purchaser by any photographic, photostatic, electronic, digital, or other similar process and such Purchaser may destroy any original document so reproduced. The Company agrees and stipulates that, to the extent permitted by
applicable law, any such reproduction shall be admissible in evidence as the original itself in any judicial or administrative proceeding (whether or not the original is in existence and whether or not such reproduction was made by such Purchaser in
the regular course of business) and any enlargement, facsimile or further reproduction of such reproduction shall likewise be admissible in evidence. This Section 17 shall not prohibit the Company or any other holder of Bonds from contesting
any such reproduction to the same extent that it could contest the original, or from introducing evidence to demonstrate the inaccuracy of any such reproduction. 

  
 -23- 

 SECTION 18. CONFIDENTIAL INFORMATION. 

For the purposes of this Section 18, “Confidential Information” means information delivered to any Purchaser by or on
behalf of the Company or any Subsidiary in connection with the transactions contemplated by or otherwise pursuant to this Agreement that is proprietary in nature and that was clearly marked or labeled or otherwise adequately identified when received
by such Purchaser as being confidential information of the Company or such Subsidiary, provided that such term does not include information that (a) was publicly known or otherwise known to such Purchaser prior to the time of such disclosure,
(b) subsequently becomes publicly known through no act or omission by such Purchaser or any person acting on such Purchaser’s behalf, (c) otherwise becomes known to such Purchaser other than through disclosure by the Company or any
Subsidiary or (d) constitutes financial statements delivered to such Purchaser under Section 7.1 of this Agreement or under the Indenture that are otherwise publicly available. Each Purchaser will maintain the confidentiality of such
Confidential Information in accordance with procedures adopted by such Purchaser in good faith to protect confidential information of third parties delivered to such Purchaser, provided that such Purchaser may deliver or disclose Confidential
Information to (i) its directors, trustees, officers, employees, agents, attorneys and affiliates (to the extent such disclosure reasonably relates to the administration of the investment represented by Bonds), (ii) its financial advisors
and other professional advisors who agree to hold confidential the Confidential Information substantially in accordance with the terms of this Section 18, (iii) any other holder of any Bond, (iv) any Institutional Investor to which it
sells or offers to sell such Bond or any part thereof or any participation therein (if such Person has agreed in writing prior to its receipt of such Confidential Information to be bound by the provisions of this Section 18), (v) any
Person from which it offers to purchase any security of the Company (if such Person has agreed in writing prior to its receipt of such Confidential Information to be bound by the provisions of this Section 18), (vi) any federal or state or
provincial regulatory authority having jurisdiction over such Purchaser, (vii) the NAIC or the SVO or, in each case, any similar organization, or any nationally recognized rating agency that requires access to information about such
Purchaser’s investment portfolio, or (viii) any other Person to which such delivery or disclosure may be necessary or appropriate (w) to effect compliance with any law, rule, regulation or order applicable to such Purchaser,
(x) in response to any subpoena or other legal process, (y) in connection with any litigation to which such Purchaser is a party or (z) if an Event of Default has occurred and is continuing, to the extent such Purchaser may reasonably
determine such delivery and disclosure to be necessary or appropriate in the enforcement or for the protection of the rights and remedies under any Financing Agreement. Each holder of a Bond, by its acceptance of a Bond, will be deemed to have
agreed to be bound by and to be entitled to the benefits of this Section 18 as though it were a party to this Agreement. On reasonable request by the Company in connection with the delivery to any holder of a Bond of information required to be
delivered to such holder under this Agreement or requested by such holder (other than a holder that is a party to this Agreement or its nominee), such holder will enter into an agreement with the Company embodying the provisions of this
Section 18. 

  
 -24- 

 In the event that as a condition to receiving access to information relating to
the Company or its Subsidiaries in connection with the transactions contemplated by or otherwise pursuant to this Agreement, any Purchaser or holder of a Bond is required to agree to a confidentiality undertaking (whether
through EMMA, another secure website, a secure virtual workspace or otherwise) which is different from this Section 18, this Section 18 shall not be amended thereby and, as between such Purchaser or such holder and
the Company, this Section 18 shall supersede any such other confidentiality undertaking. 
 SECTION 19.
MISCELLANEOUS. 
 Section 19.1. Successors and Assigns. All covenants and other agreements contained in this
Agreement by or on behalf of any of the parties hereto bind and inure to the benefit of their respective successors and assigns (including, without limitation, any subsequent holder of a Bond) whether so expressed or not. 

Section 19.2. Accounting Terms. All accounting terms used herein which are not expressly defined in this Agreement have the
meanings respectively given to them in accordance with GAAP. Except as otherwise specifically provided herein, (a) all computations made pursuant to this Agreement shall be made in accordance with GAAP, and (b) all financial statements
shall be prepared in accordance with GAAP. For purposes of determining compliance with the financial covenants contained in the Financing Agreements, if any, any election by the Company to measure Debt using fair value (as permitted by Financial
Accounting Standards Board Accounting Standards Codification Topic No. 825-10-25 – Fair Value Option, International Accounting
Standard 39 –Financial Instruments: Recognition and Measurement or any similar accounting standard) shall be disregarded and such determination shall be made as if such election had not been made and such Debt shall be valued
at not less than 100% of the principal amount thereof. 
 Section 19.3. Severability. Any provision of this Agreement that is
prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability
in any jurisdiction shall (to the full extent permitted by law) not invalidate or render unenforceable such provision in any other jurisdiction. 

Section 19.4. Construction, Etc. Each covenant contained herein shall be construed (absent express provision to the contrary) as
being independent of each other covenant contained herein, so that compliance with any one covenant shall not (absent such an express contrary provision) be deemed to excuse compliance with any other covenant. Where any provision herein refers to
action to be taken by any Person, or which such Person is prohibited from taking, such provision shall be applicable whether such action is taken directly or indirectly by such Person. 

  
 -25- 

 For the avoidance of doubt, all Schedules and Exhibits attached to this Agreement shall be deemed
to be a part hereof. 
 Section 19.5. Counterparts. This Agreement may be executed in any number of counterparts, each of which
shall be an original but all of which together shall constitute one instrument. Each counterpart may consist of a number of copies hereof, each signed by less than all, but together signed by all, of the parties hereto. 

Section 19.6. Governing Law. This Agreement shall be construed and enforced in accordance with, and the rights of the parties
shall be governed by, the law of the Commonwealth of Pennsylvania excluding choice-of-law principles of the law of such State that would permit the application of the
laws of a jurisdiction other than such State. 
 Section 19.7. Jurisdiction and Process; Waiver of Jury Trial. (a) The
Company irrevocably submits to the non-exclusive jurisdiction of any Pennsylvania State or federal court sitting in Philadelphia, Pennsylvania, over any suit, action or proceeding arising out of or relating to this Agreement or the Bonds. To the
fullest extent permitted by applicable law, the Company irrevocably waives and agrees not to assert, by way of motion, as a defense or otherwise, any claim that it is not subject to the jurisdiction of any such court, any objection that it may now
or hereafter have to the laying of the venue of any such suit, action or proceeding brought in any such court and any claim that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum. 

(b) The Company consents to process being served by or on behalf of any holder of Bonds in any suit, action or proceeding of the nature
referred to in Section 19.7(a) by mailing a copy thereof by registered or certified mail (or any substantially similar form of mail), postage prepaid, return receipt requested, to it at its address specified in Section 15 or at such other
address of which such holder shall then have been notified pursuant to said Section. The Company agrees that such service upon receipt (i) shall be deemed in every respect effective service of process upon it in any such suit, action or
proceeding and (ii) shall, to the fullest extent permitted by applicable law, be taken and held to be valid personal service upon and personal delivery to it. Notices hereunder shall be conclusively presumed received as evidenced by a delivery
receipt furnished by the United States Postal Service or any reputable commercial delivery service. 
 (c) Nothing in this Section 19.7
shall affect the right of any holder of a Bond to serve process in any manner permitted by law, or limit any right that the holders of any of the Bonds may have to bring proceedings against the Company in the courts of any appropriate jurisdiction
or to enforce in any lawful manner a judgment obtained in one jurisdiction in any other jurisdiction. 
 (d) The parties hereto hereby waive
trial by jury in any action brought on or with respect to this Agreement, the Bonds or any other document executed in connection herewith or therewith. 

  
 -26- 

 Section 19.8. Payments Due on Non-Business Days. Anything in this Agreement or the
Bonds to the contrary notwithstanding (but without limiting the requirement in Section 8.4 that the notice of any optional prepayment specify a Business Day as the date fixed for such prepayment), any payment of principal of or Make-Whole
Amount or interest on any Bond that is due on a date other than a Business Day shall be made on the next succeeding Business Day without including the additional days elapsed in the computation of the interest payable on such next succeeding
Business Day; provided that if the maturity date of any Bond is a date other than a Business Day, the payment otherwise due on such maturity date shall be made on the next succeeding Business Day and shall include the additional days elapsed in the
computation of interest payable on such next succeeding Business Day. 
 *   *   *   *   * 

  
 -27- 

 If you are in agreement with the foregoing, please sign the form of agreement on a counterpart of
this Bond Purchase Agreement and return it to the Company, whereupon this Agreement shall become a binding agreement between you and the Company. 
  

			
	Very truly yours,
	
	AQUA PENNSYLVANIA, INC.
		
	By	 	 /s/ David P. Smeltzer

	 Name: David P. Smeltzer

	 Its: Executive Vice President, Chief Financial Officer

  
 -28- 

					
	AQUA PENNSYLVANIA, INC.	  		  	Bond Purchase Agreement

 Accepted as of the date first written above. 

 

			
	JOHN HANCOCK LIFE INSURANCE COMPANY
	(U.S.A)
		
	By	 	 /s/ Pradeep Killamsetty

		 	Name: Pradeep Killamsetty
		 	Title: Managing Director
	
	JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK
		
	By	 	 /s/ Pradeep Killamsetty

		 	Name: Pradeep Killamsetty
		 	Title: Managing Director
	
	JOHN HANCOCK LIFE & HEALTH INSURANCE COMPANY
		
	By	 	 /s/ Pradeep Killamsetty

		 	Name: Pradeep Killamsetty
		 	Title: Managing Director

					
	AQUA PENNSYLVANIA, INC.	  		  	Bond Purchase Agreement

 Accepted as of the date first written above. 

 

			
	THE LINCOLN NATIONAL LIFE INSURANCE COMPANY
	
	By: Delaware Investment Advisers, a series of Delaware Management Business Trust, Attorney in Fact
		
	By	 	 /s/ Karl H. Spaeth, Jr.

		 	Name: Karl H. Spaeth, Jr.
		 	Title: Vice President

					
	AQUA PENNSYLVANIA, INC.	  		  	Bond Purchase Agreement

 Accepted as of the date first written above. 

 

			
	THRIVENT FIANCIAL FOR LUTHERAN
		
	By	 	 /s/ Patricia Eitrheim

		 	Name: Patricia Eitrheim
		 	Title: Director

					
	AQUA PENNSYLVANIA, INC.	  		  	Bond Purchase Agreement

 Accepted as of the date first written above. 

 

			
	UNITED INSURANCE COMPANY OF AMERICA
	EQUITABLE LIFE & CASUALTY INSURNACE COMPANY
	 CATHOLIC UNITED FINANCIAL

	GREAT WESTERN INSURANCE COMPANY
		
	 By:
	 	Advantus Capital Management, Inc.
		
	By	 	 /s/ James F. Geiger

		 	Name: James F. Geiger
		 	Title: Vice President

 INFORMATION RELATING TO PURCHASERS

  

					
		  	NAME AND ADDRESS OF PURCHASER	  	PRINCIPAL AMOUNT OF
BONDS TO BE PURCHASED
			
		  	[NAME OF PURCHASER]	  	$

  

	(1)	All payments by wire transfer of immediately available funds to: 

 with sufficient information
to identify the source and application of such funds. 
  

	(2)	All notices of payments and written confirmations of such wire transfers: 

  

	(3)	All other communications: 

 SCHEDULE A 

(to Bond Purchase Agreement) 

 DEFINED TERMS 

As used herein, the following terms have the respective meanings set forth below or set forth in the Section hereof following such term: 

“Affiliate” means, at any time, and with respect to any Person, any other Person that at such time directly or indirectly through one or more
intermediaries Controls, or is Controlled by, or is under common Control with, such first Person. As used in this definition, “Control” means the possession, directly or indirectly, of the power to direct or cause the direction of
the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise. Unless the context otherwise clearly requires, any reference to an “Affiliate” is a reference to an Affiliate of
the Company. 
 “Anti-Money Laundering Laws” is defined in Section 5.16(c). 

“Blocked Person” is defined in Section 5.16(a). 

“Bonds” is defined in Section 1. 

“Business Day” means for the purposes of any provision of this Agreement, any day other than a Saturday, a Sunday or a day on
which commercial banks in New York, New York or Philadelphia, Pennsylvania are required or authorized to be closed. 

“Capital Lease” means, at any time, a lease with respect to which the lessee is required concurrently to recognize the
acquisition of an asset and the incurrence of a liability in accordance with GAAP. 
 “Capital Lease Obligation” means,
with respect to any Person and a Capital Lease, the amount of the obligation of such Person as the lessee under such Capital Lease which would, in accordance with GAAP, appear as a liability on a balance sheet of such Person. 

“CISADA” means the Comprehensive Iran Sanctions, Accountability, and Divestment Act of 2010, United States Public Law 111195,
as amended from time to time, and the rules and regulations promulgated thereunder from time to time in effect. 

“Closing” is defined in Section 3. 

“Closing Date” is the date of the Closing. 

“Code” means the Internal Revenue Code of 1986, as amended from time to time, and the rules and regulations promulgated
thereunder from time to time. 
 “Company” means Aqua Pennsylvania, Inc., a corporation existing under the laws of the
Commonwealth of Pennsylvania. 
 SCHEDULE B 

(to Bond Purchase Agreement) 

 “Controlled Entity” means any of the Subsidiaries of the Company and any of
their or the Company’s respective Controlled Affiliates. As used in this definition, “Control” means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person,
whether through the ownership of voting securities, by contract or otherwise. 
 “Debt” means, with respect to any Person,
without duplication, 
 (a) its liabilities for borrowed money; 

(b) its liabilities for the deferred purchase price of property acquired by such Person (excluding accounts payable and other
accrued liabilities arising in the ordinary course of business but including, without limitation, all liabilities created or arising under any conditional sale or other title retention agreement with respect to any such property); 

(c) its Capital Lease Obligations; 

(d) all liabilities for borrowed money secured by any Lien with respect to any property owned by such Person (whether or not it
has assumed or otherwise become liable for such liabilities); 
 (e) all non-contingent liabilities in respect of
reimbursement agreements or similar agreements in respect of letters of credit or instruments serving a similar function issued or accepted for its account by banks and other financial institutions; 

(f) Swaps of such Person; and 

(g) Guaranties of such Person with respect to liabilities of a type described in any of clauses (a) through
(f) hereof. 
 Debt of any Person shall include all obligations of such Person of the character described in clauses (a) through
(g) to the extent such Person remains legally liable in respect thereof notwithstanding that any such obligation is deemed to be extinguished under GAAP. 

“Default” means an event or condition the occurrence or existence of which would, with the lapse of time or the giving of
notice or both, become an Event of Default. 
 “Disclosure Documents” is defined in Section 5.3. 

“EMMA” is defined in Section 7.1(a). 

“Environmental Laws” means any and all Federal, state, local, and foreign statutes, laws, regulations, ordinances, rules,
judgments, orders, decrees, permits, concessions, grants, franchises, licenses, agreements or governmental restrictions relating to pollution and the protection of the environment or the release of any materials into the environment, including but
not limited to those related to Hazardous Materials. 

  
 B-2 

 “ERISA” means the Employee Retirement Income Security Act of 1974, as amended
from time to time, and the rules and regulations promulgated thereunder from time to time in effect. 
 “ERISA Affiliate”
means any trade or business (whether or not incorporated) that is treated as a single employer together with the Company under section 414 of the Code. 

“Event of Default” is defined in the Indenture. 

“Financing Agreements” means this Agreement, the Indenture (including without limitation the Supplement), and the Bonds. 

“GAAP” means generally accepted accounting principles as in effect from time to time in the United States of America. 

“Governmental Authority” means: 

(a) the government of 

(i) the United States of America or any State or other political subdivision thereof, or 

(ii) any other jurisdiction in which the Company or any Subsidiary conducts all or any part of its business, or which asserts
jurisdiction over any properties of the Company or any Subsidiary, or 
 (b) any entity exercising executive, legislative,
judicial, regulatory or administrative functions of, or pertaining to, any such government. 
 “Guaranty” means, with
respect to any Person, any obligation (except the endorsement in the ordinary course of business of negotiable instruments for deposit or collection) of such Person guaranteeing or in effect guaranteeing any Debt, dividend or other obligation of any
other Person in any manner, whether directly or indirectly, including (without limitation) obligations incurred through an agreement, contingent or otherwise, by such Person: 

(a) to purchase such Debt or obligation or any property constituting security therefor primarily for the purpose of assuring
the owner of such Debt or obligation of the ability of any other Person to make payment of the Debt or obligation; 
 (b) to
advance or supply funds (i) for the purchase or payment of such Debt or obligation, or (ii) to maintain any working capital or other balance sheet condition or any income statement condition of any other Person or otherwise to advance or
make available funds for the purchase or payment of such Debt or obligation; 

  
 B-3 

 (c) to lease properties or to purchase properties or services primarily for the
purpose of assuring the owner of such Debt or obligation of the ability of any other Person to make payment of the Debt or obligation; or 

(d) otherwise to assure the owner of such Debt or obligation against loss in respect thereof. 

In any computation of the Debt or other liabilities of the obligor under any Guaranty, the Debt or other obligations that are the subject of
such Guaranty shall be assumed to be direct obligations of such obligor, provided that the amount of such Debt outstanding for purposes of this Agreement shall not exceed the maximum amount of Debt that is the subject of such Guaranty. 

“Hazardous Material” means any and all pollutants, toxic or hazardous wastes or other substances that might pose a hazard to
health and safety, the removal of which may be required or the generation, manufacture, refining, production, processing, treatment, storage, handling, transportation, transfer, use, disposal, release, discharge, spillage, seepage or filtration of
which is or shall be restricted, prohibited or penalized by any applicable law including, but not limited to, asbestos, urea formaldehyde foam insulation, polychlorinated biphenyls, petroleum, petroleum products, lead based paint, radon gas or
similar restricted, prohibited or penalized substances. 
 “holder” is defined in the Indenture. 

“Indenture” is defined in Section 1. 

“Institutional Investor” means (a) any Purchaser of a Bond, (b) any holder of a Bond holding (together with one or
more of its affiliates) more than 5% of the aggregate principal amount of the Bonds then outstanding, (c) any bank, trust company, savings and loan association or other financial institution, any pension plan, any investment company, any
insurance company, any broker or dealer, or any other similar financial institution or entity, regardless of legal form, and (d) any Related Fund of any holder of any Bond. 

“Lien” means, with respect to any Person, any mortgage, lien, pledge, charge, security interest or other encumbrance, or any
interest or title of any vendor, lessor, lender or other secured party to or of such Person under any conditional sale or other title retention agreement or Capital Lease, upon or with respect to any property or asset of such Person (including in
the case of stock, stockholder agreements, voting trust agreements and all similar arrangements). 
 “Make-Whole Amount” is
defined in the Supplement. 
 “Material” means material in relation to the business, operations, affairs, financial
condition, assets or properties of the Company and its Subsidiaries taken as a whole. 

  
 B-4 

 “Material Adverse Effect” means a material adverse effect on (a) the
business, operations, affairs, financial condition, assets or properties of the Company and its Subsidiaries taken as a whole, (b) the ability of the Company to perform its obligations under this Agreement, the Bonds or the Indenture or
(c) the validity or enforceability of any Financing Agreement. 
 “Multiemployer Plan” means any Plan that is a
“multiemployer plan” (as such term is defined in section 4001(a)(3) of ERISA). 
 “NAIC” means the National
Association of Insurance Commissioners or any successor thereto. 
 ‘OFAC” is defined in Section 5.16(a). 

“OFAC Listed Person” is defined in Section 5.16(a). 

“OFAC Sanctions Program” means all laws, regulations, Executive Orders and any economic or trade sanction that OFAC is
responsible for administering and enforcing, including, without limitation 31 CFR Subtitle B, Chapter V, as amended, along with any enabling legislation; the Bank Secrecy Act; Trading with the Enemy Act; and any similar laws, regulations or orders
adopted by any State within the United States. A list of economic and trade sanctions administered by OFAC may be found at http://www.ustreas.gov/offices/enforcement/ofac/programs/. 

“Officer’s Certificate” means a certificate of a Senior Financial Officer or of any other officer of the Company whose
responsibilities extend to the subject matter of such certificate. 
 “Original Indenture” is defined in Section 1.

 “PBGC” means the Pension Benefit Guaranty Corporation referred to and defined in ERISA or any successor thereto. 

“Permitted Liens” shall have the meaning assigned to such term in the Indenture. 

“Person” means an individual, partnership, corporation, limited liability company, association, trust, unincorporated
organization, business entity or Governmental Authority. 
 “Plan” means an “employee benefit plan” (as defined
in section 3(2) of ERISA) subject to Title I of ERISA that is or, within the preceding five years, has been established or maintained, or to which contributions are or, within the preceding five years, have been made or required to be made, by
the Company or any ERISA Affiliate or with respect to which the Company or any ERISA Affiliate may have any liability. 

“property” or “properties” means, unless otherwise specifically limited, real or personal property of any
kind, tangible or intangible, choate or inchoate. 
 “PTE” is defined in Section 6.2(a). 

“Purchaser” is defined in the first paragraph of this Agreement. 

  
 B-5 

 “Related Fund” means, with respect to any holder of any Bond, any fund or entity
that (i) invests in Securities or bank loans, and (ii) is advised or managed by such holder, the same investment advisor as such holder or by an affiliate of such holder or such investment advisor. 

“Required Holders” means, at any time, the holders of at least 51% in principal amount of the Bonds at the time outstanding
(exclusive of Bonds then owned by the Company or any of its Affiliates). 
 “Responsible Officer” means any Senior
Financial Officer and any other officer of the Company with responsibility for the administration of the relevant portion of this Agreement. 

“SEC” means the Securities and Exchange Commission of the United States, or any successor thereto. 

“Securities” or “Security” shall have the meaning specified in Section 2(1) of the Securities Act. 

“Securities Act” means the Securities Act of 1933, as amended from time to time, and the rules and regulations promulgated
thereunder from time to time in effect. 
 “Senior Financial Officer” means the chief financial officer, principal
accounting officer, treasurer or comptroller of the Company. 
 “Source” is defined in Section 6.2. 

“Subsidiary” means, as to any Person, any other Person in which such first Person or one or more of its Subsidiaries or such
first Person and one or more of its Subsidiaries owns sufficient equity or voting interests to enable it or them (as a group) ordinarily, in the absence of contingencies, to elect a majority of the directors (or Persons performing similar functions)
of such second Person, and any partnership or joint venture if more than a 50% interest in the profits or capital thereof is owned by such first Person or one or more of its Subsidiaries or such first Person and one or more of its Subsidiaries
(unless such partnership or joint venture can and does ordinarily take major business actions without the prior approval of such Person or one or more of its Subsidiaries. Unless the context otherwise clearly requires, any reference to a
“Subsidiary” is a reference to a Subsidiary of the Company. 
 “Supplement” is defined in Section 1. 

“SVO” means the Securities Valuation Office of the NAIC or any successor to such Office. 

“Swaps” means, with respect to any Person, payment obligations with respect to interest rate swaps, currency swaps and
similar obligations obligating such Person to make payments, whether periodically or upon the happening of a contingency. For the purposes of this Agreement, the amount of the obligation under any Swap shall be the amount determined in respect
thereof as of the end of the then most recently ended fiscal quarter of such Person, based on the assumption that such Swap had terminated at the end of such fiscal quarter, and in making such determination, if any agreement relating to such Swap
provides for the netting of amounts payable by and to such Person thereunder or if any such agreement provides for the simultaneous payment of amounts by and to such Person, then in each such case, the amount of such obligation shall be the net
amount so determined. 

  
 B-6 

 “Trust Estate” is defined in Section 1. 

“Trustee” is defined in the Indenture. 

“UCC” means, the Uniform Commercial Code as enacted and in effect from time to time in the state whose laws are treated as
applying to the Trust Estate. 
 “USA Patriot Act” means United States Public Law
107-56, Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism (USA PATRIOT ACT) Act of 2001, as amended from time to time, and the rules and regulations
promulgated thereunder from time to time in effect. 

  
 B-7 

 AQUA PENNSYLVANIA, INC. 

SUBSIDIARIES OF THE COMPANY, 

OWNERSHIP OF SUBSIDIARY STOCK 

 

									
	 Company Name
	  	State of
Incorporation	 	  	% of
Ownership
(Direct &
Indirect)	 
	 Aqua Pennsylvania, Inc.
	  	 	Pennsylvania	  	  	 	100	% 
	 1. Little Washington Wastewater Company
	  	 	Pennsylvania	  	  	 	100	% 
	 2. The Hawley Water Company*
	  	 	Pennsylvania	  	  	 	90	% 
	 3. Honesdale Consolidated Water Company
	  	 	Pennsylvania	  	  	 	100	% 
		  				  			

  

	*	Partially owned by minority shareholders 

 SCHEDULE 5.4 

(to Bond Purchase Agreement) 

 FINANCIAL STATEMENTS 

 

	1.	Aqua Pennsylvania, Inc. Consolidated Financial Statements as of and for the year ended Dec 31, 2008 and 2007 (audited) 

  

	2.	Aqua Pennsylvania, Inc. Consolidated Financial Statements as of and for the year ended Dec 31, 2009 and 2008 (audited) 

  

	3.	Aqua Pennsylvania, Inc. Consolidated Financial Statements as of and for the year ended Dec 31, 2010 and 2009 (audited) 

  

	4.	Aqua Pennsylvania, Inc. Consolidated Financial Statements as of and for the year ended Dec 31, 2011 and 2010 (audited) 

  

	5.	Aqua Pennsylvania, Inc. Consolidated Financial Statements as of and for the year ended Dec 31, 2012 and 2011 (audited) 

  

	6.	Aqua Pennsylvania, Inc. Report for Quarter Ended June 30, 2013 

 SCHEDULE
5.5 
 (to Bond Purchase Agreement) 

 SCHEDULE 5.15(A) 

EXISTING DEBT 

Aqua Pennsylvania and Subsidiaries 

Schedule 5.15(a) - Existing Debt as of 6/30/13 
  

									
	 	  	 	 	 	Outstanding
Balance	 
	 Unsecured Note
	  	 	5.50	% 	 	 	2,132,180	  
	 Unsecured Note
	  	 	5.64	% 	 	 	4,584,000	  
	 Unsecured Note
	  	 	5.64	% 	 	 	4,489,000	  
	 Unsecured Note
	  	 	5.64	% 	 	 	5,466,000	  
	 Unsecured Note
	  	 	5.64	% 	 	 	5,461,000	  
	 Unsecured Note
	  	 	5.66	% 	 	 	40,000,000	  
	 Unsecured Note
	  	 	5.95	% 	 	 	10,000,000	  
	 Unsecured Note
	  	 	5.95	% 	 	 	10,000,000	  
	 Unsecured Note
	  	 	5.95	% 	 	 	10,000,000	  
	 Unsecured Note
	  	 	5.95	% 	 	 	10,000,000	  
	 Note
	  	 	9.00	% 	 	 	187,158	  
		  				 	  
	  
	 
	 Total Unsecured Notes
	  				 	 	102,319,338	  
	 Tax Exempt (FGIC)
	  	 	5.05	% 	 	 	14,000,000	  
	 Tax Exempt (AMBAC)
	  	 	5.15	% 	 	 	25,000,000	  
	 Tax Exempt (FGIC)
	  	 	5.00	% 	 	 	21,770,000	  
	 Tax Exempt (FGIC)
	  	 	5.00	% 	 	 	24,165,000	  
	 Tax Exempt (FGIC)
	  	 	5.00	% 	 	 	25,375,000	  
	 Tax Exempt-Bond Premium
	  				 	 	516,331	  
	 Tax Exempt (FGIC)
	  	 	5.00	% 	 	 	24,675,000	  
	 Tax Exempt-Bond Premium
	  				 	 	239,412	  
	 Tax Exempt (FGIC)
	  	 	5.00	% 	 	 	23,915,000	  
	 Tax Exempt (FGIC)
	  	 	5.00	% 	 	 	23,915,000	  
	 Tax Exempt-Bond Premium
	  				 	 	1,751,740	  
	 Tax Exempt (No Ins. - S&P)
	  	 	5.25	% 	 	 	24,830,000	  
	 Tax Exempt
	  	 	5.25	% 	 	 	24,830,000	  
	 Tax Exempt-Bond Premium
	  				 	 	284,940	  
	 Tax Exempt
	  	 	6.25	% 	 	 	9,000,000	  
	 Tax Exempt
	  	 	6.75	% 	 	 	13,000,000	  
	 Tax Exempt-Bond Discount
	  				 	 	(86,700	) 
	 Tax Exempt
	  	 	5.00	% 	 	 	58,000,000	  
	 Tax Exempt-Bond Discount
	  				 	 	(1,757,811	) 
	 Tax Exempt
	  	 	5.00	% 	 	 	62,165,000	  
	 Tax Exempt-Bond Premium
	  				 	 	538,184	  
	 Tax Exempt
	  	 	4.75	% 	 	 	12,520,000	  
	 Tax Exempt-Bond Discount
	  				 	 	(263,418	) 
	 Tax Exempt
	  	 	5.00	% 	 	 	25,910,000	  
	 Tax Exempt
	  	 	5.00	% 	 	 	19,270,000	  

  
 SCHEDULE
5.15(a) 
 (to Bond Purchase Agreement) 

									
	 	  	 	 	 	Outstanding
Balance	 
	 Tax Exempt-Bond Discount
	  				 	 	(119,107	) 
	 Tax Exempt
	  	 	4.50	% 	 	 	15,000,000	  
	 Tax Exempt-Bond Discount
	  				 	 	(564,000	) 
	 Tax Exempt
	  	 	5.00	% 	 	 	81,205,000	  
	 Tax Exempt-Bond Premium
	  				 	 	2,380,650	  
		  				 	  
	  
	 
	 Total Tax Exempt Bonds
	  				 	 	531,465,221	  
	 PennVest
	  	 	1.372	% 	 	 	643,593	  
	 PennVest
	  	 	1.274	% 	 	 	1,079,172	  
	 PennVest
	  	 	1.274	% 	 	 	396,686	  
	 PennVest
	  	 	1.559	% 	 	 	1,059,138	  
	 PennVest
	  	 	1.274	% 	 	 	921,155	  
	 PennVest
	  	 	1.274	% 	 	 	307,606	  
	 PennVest
	  	 	1.000	% 	 	 	2,790,954	  
	 PennVest
	  	 	1.000	% 	 	 	1,115,874	  
	 PennVest
	  	 	3.237	% 	 	 	377,423	  
	 PennVest
	  	 	2.400	% 	 	 	78,246	  
	 PennVest
	  	 	3.237	% 	 	 	182,090	  
	 PennVest
	  	 	1.000	% 	 	 	52,958	  
	 PennVest
	  	 	2.842	% 	 	 	2,427,947	  
	 PennVest
	  	 	1.000	% 	 	 	204,210	  
	 PennVest
	  	 	2.400	% 	 	 	204,699	  
	 PennVest
	  	 	3.237	% 	 	 	580,206	  
	 PennVest
	  	 	1.551	% 	 	 	635,049	  
	 PennVest
	  	 	2.752	% 	 	 	5,923,556	  
	 PennVest
	  	 	2.774	% 	 	 	460,958	  
	 PennVest
	  	 	1.387	% 	 	 	1,922,253	  
	 PennVest
	  	 	3.237	% 	 	 	331,266	  
	 PennVest
	  	 	3.003	% 	 	 	1,193,328	  
	 PennVest
	  	 	3.045	% 	 	 	677,361	  
	 PennVest
	  	 	2.774	% 	 	 	811,383	  
	 PennVest
	  	 	1.387	% 	 	 	1,066,485	  
	 PennVest
	  	 	2.769	% 	 	 	3,945,692	  
	 PennVest
	  	 	2.702	% 	 	 	226,409	  
	 PennVest
	  	 	2.556	% 	 	 	1,692,762	  
	 PennVest
	  	 	1.278	% 	 	 	901,660	  
	 PennVest
	  	 	1.278	% 	 	 	1,069,517	  
	 PennVest
	  	 	1.274	% 	 	 	410,677	  
	 PennVest
	  	 	2.270	% 	 	 	1,204,947	  
	 PennVest
	  	 	1.274	% 	 	 	1,221,431	  
	 PennVest
	  	 	1.274	% 	 	 	908,771	  
	 PennVest
	  	 	1.274	% 	 	 	682,528	  
	 PennVest
	  	 	2.464	% 	 	 	1,486,692	  

  
 5.15(a)-2 

									
	 	  	 	 	 	Outstanding
Balance	 
	 PennVest
	  	 	1.274	% 	 	 	124,491	  
	 PennVest
	  	 	1.000	% 	 	 	6,731,642	  
	 PennVest
	  	 	2.501	% 	 	 	404,075	  
	 PennVest
	  	 	1.380	% 	 	 	3,204,266	  
	 PennVest
	  	 	1.362	% 	 	 	1,474,543	  
	 PennVest
	  	 	1.274	% 	 	 	940,625	  
	 PennVest
	  	 	1.000	% 	 	 	398,628	  
	 PennVest
	  	 	1.387	% 	 	 	216,645	  
	 PennVest
	  	 	1.387	% 	 	 	199,561	  
	 PennVest
	  	 	1.942	% 	 	 	751,846	  
	 PennVest
	  	 	2.774	% 	 	 	5,357,835	  
	 PennVest
	  	 	1.387	% 	 	 	1,321,412	  
	 PennVest
	  	 	1.000	% 	 	 	406,975	  
	 PennVest
	  	 	1.387	% 	 	 	1,467,138	  
	 PennVest
	  	 	2.568	% 	 	 	1,749,661	  
	 PennVest
	  	 	1.274	% 	 	 	1,463,236	  
		  				 	  
	  
	 
	 Total PennVest
	  				 	 	65,407,261	  
	 FMB
	  	 	5.08	% 	 	 	20,000,000	  
	 FMB
	  	 	5.17	% 	 	 	7,000,000	  
	 FMB
	  	 	5.751	% 	 	 	15,000,000	  
	 FMB
	  	 	5.751	% 	 	 	5,000,000	  
	 FMB
	  	 	5.98	% 	 	 	3,000,000	  
	 FMB
	  	 	6.06	% 	 	 	15,000,000	  
	 FMB
	  	 	6.06	% 	 	 	5,000,000	  
	 FMB
	  	 	6.89	% 	 	 	12,000,000	  
	 FMB
	  	 	7.72	% 	 	 	15,000,000	  
	 FMB-Shenango
	  	 	8.14	% 	 	 	4,000,000	  
	 FMB
	  	 	9.17	% 	 	 	3,600,000	  
	 FMB
	  	 	9.29	% 	 	 	12,000,000	  
	 FMB
	  	 	9.97	% 	 	 	5,000,000	  
	 FMB
	  	 	3.79	% 	 	 	40,000,000	  
	 FMB
	  	 	3.80	% 	 	 	20,000,000	  
	 FMB
	  	 	3.85	% 	 	 	20,000,000	  
		  				 	  
	  
	 
	 Total First Mortgage Bonds
	  				 	 	201,600,000	  
	 PennVest - LWWW
	  	 	1.00	% 	 	 	1,093,088	  
	 PennVest - LWWW
	  	 	1.00	% 	 	 	124,361	  
	 PennVest - LWWW
	  	 	1.00	% 	 	 	1,596,914	  
	 PennVest - LWWW
	  	 	1.00	% 	 	 	649,570	  
	 PennVest - LWWW
	  	 	1.000	% 	 	 	323,244	  
	 PennVest - LWWW
	  	 	1.000	% 	 	 	150,843	  

  
 5.15(a)-3 

									
	 	  	 	 	 	Outstanding
Balance	 
	 PennVest - LWWW
	  	 	1.387	% 	 	 	273,895	  
	 PennVest - LWWW
	  	 	3.336	% 	 	 	16,026	  
	 PennVest - LWWW
	  	 	1.000	% 	 	 	732,270	  
		  				 	  
	  
	 
	 Total PennVest LWWW
	  				 	 	4,960,212	  
	 Total Long Term Debt
	  				 	 	905,752,031	  
		  				 	  
	  
	 
	 PNC Revolver
	  				 	 	95,006,266	  
	 PNC Uncommitted line
	  				 	 	8,000,000	  
		  				 	  
	  
	 
	 Total Debt Aqua Pennsylvania
	  				 	 	1,008,758,297	  
		  				 	  
	  
	 

  
 5.15(a)-4 

 SCHEDULE 5.15(b) 

AQUA PENNSYLVANIA, INC. AND SUBSIDIARIES 

DEBT ISSUANCE LIMITATIONS 

Indenture of Mortgage dated as of January 1, 1941 of Aqua Pennsylvania, Inc. as Supplemented and Amended 

$100 million Revolving Credit Agreement among Aqua Pennsylvania, Inc. and PNC Bank, 

National Association as Agent as Amended and Dated as of November 26, 2012 

Aqua Pennsylvania, Inc. $40,000,000 5.95% Senior Notes dated March 31, 2006 

Aqua Pennsylvania, Inc. $20,000,000 5.64% Senior Notes dated September 29, 2006 

Aqua Pennsylvania, Inc. $2,132,180 5.50% Senior Notes dated May 15, 2007 

Aqua Pennsylvania, Inc. $40,000,000 5.66% Senior Notes dated December 28, 2007 

SCHEDULE 5.15(b) 

(to Bond Purchase Agreement) 

 [FORM OF SUPPLEMENT] 

[SEE ATTACHED] 

EXHIBIT A 
 (to Bond
Purchase Agreement) 

 FORM OF OPINION OF
SPECIAL COUNSEL 
 TO THE COMPANY 

[SEE ATTACHED] 

EXHIBIT 4.4(a)(i) 

(to Bond Purchase Agreement) 

 FORM OF OPINION OF
GENERAL COUNSEL 
 TO THE COMPANY 

[SEE ATTACHED] 

EXHIBIT 4.4(a)(ii) 

(to Bond Purchase Agreement) 

 FORM OF OPINION OF
SPECIAL COUNSEL 
 TO THE PURCHASERS 

[DELIVERED TO PURCHASERS ONLY] 

EXHIBIT 4.4(b) 

(to Bond Purchase Agreement)EX-10.2 (d)

 Exhibit 10.2(d) 

PUMA BIOTECHNOLOGY, INC. 
 2011 INCENTIVE AWARD PLAN 
 PERFORMANCE SHARE AWARD GRANT NOTICE

 Puma Biotechnology, Inc., a Delaware corporation, (the “Company”), pursuant to the Puma
Biotechnology, Inc. 2011 Incentive Award Plan, as amended from time to time (the “Plan”), hereby grants to the individual listed below (the “Participant”), in consideration of the mutual agreements set
forth herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, a Performance Share Award (the “Performance Shares”). This Performance Share Award represents the right
to receive a range of shares of Common Stock (as defined in the Plan) (“Shares”) based on the attainment of stock price objectives over the applicable vesting period. This award is subject to all of the terms and conditions
set forth herein and in the Performance Share Award Agreement attached hereto as Exhibit A (the “Performance Share Award Agreement”) and the Plan, each of which are incorporated herein by reference. Unless otherwise
defined herein, the terms defined in the Plan shall have the same defined meanings in this Performance Share Award Grant Notice (the “Grant Notice”) and the Performance Share Award Agreement attached hereto as Exhibit
A (together with the Grant Notice, the “Agreement”). 
  

			
		
	Participant:	    	[                              
          ]
		
	Grant Date:	    	[                    ]
		
	Maximum Number of Performance Shares:	    	[                    ]
		
	Performance Goals:	    	Except as otherwise set forth in the Performance Share Award Agreement, the Participant is eligible to receive Shares based upon the Company’s attainment, during the
Performance Period, of the Performance Goal as of each Vesting Date as set forth in Section 2.2 of the Performance Share Award Agreement.
		
	Termination:	    	This Performance Share Award shall terminate, and the Participant shall forfeit all then-unvested Performance Shares (after taking into consideration any accelerated vesting that
may occur in connection with such termination of employment, if any), in each case, upon the Participant’s termination of employment.

 By his or her signature and the Company’s signature below, the Participant agrees to be bound by the
terms and conditions of the Plan and this Agreement. The Participant has reviewed this Agreement and the Plan in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement and fully understands all
provisions of this Grant Notice, the Performance Share Award Agreement and the Plan. The Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator of the Plan upon any questions
arising under the Plan or this Agreement. In addition, by signing below, the Participant also agrees that, unless otherwise determined by the Administrator, the Company shall satisfy any withholding obligations in accordance with Section 3.4 of
the Performance Share Award Agreement by withholding Shares otherwise issuable to the Participant in connection with the vesting and/or payment of the Performance Shares. If the Participant is married, his or her spouse has signed the Consent of
Spouse attached to this Agreement as Exhibit B. 

									
	PUMA BIOTECHNOLOGY, INC.:	 		 	PARTICIPANT:
					
	By:	 	  
	 		 	By:	 	  

	Print Name:	 	  
	 		 	Print Name:	 	  

	Title:	 	  
	 		 		 	
	Address:	 	  
	 		 	Address:	 	  

		 	  
	 		 		 	  

 EXHIBIT A 
 TO PERFORMANCE SHARE AWARD GRANT NOTICE 
 PERFORMANCE SHARE AWARD
AGREEMENT 
 Pursuant to this Agreement, the Company hereby grants to the Participant the Performance Shares pursuant to the
terms and conditions set forth in this Agreement. 
 ARTICLE 1. 

GENERAL 

1.1 Defined Terms. Wherever the following terms are used in this Agreement they shall have the meanings specified below, unless
the context clearly indicates otherwise. Capitalized terms not specifically defined herein shall have the meanings specified in the Plan and the Grant Notice. 
 (a) “Baseline Stock Price” shall mean $[        ]. 
 (b) “Grant Date” shall be the date set forth in the Grant Notice. 
 (c) “Maximum Stock Price” shall mean $[        ]. 
 (d) “Performance Goal” shall mean, with respect to a Vesting Date, the achievement of a Fair Market Value on such Vesting Date that is greater than the Baseline Stock Price.

 (e) “Performance Period” shall mean the period beginning on the Grant Date and ending on
[        ]. 
 (f) “Reference Number” shall mean
[        ], as may be adjusted by the Administrator in connection with any accelerated vesting, if any. 
 (g) “Vesting Date” shall mean [        ] of each of
[        ],[        ] and [        ], or any earlier date on which accelerated vesting may occur, as determined in the sole
discretion of the Administrator. 
 1.2 Incorporation of Terms of Plan. The Performance Shares are subject to the terms
and conditions of the Plan, which are incorporated herein by reference. Except as expressly indicated herein, in the event of any inconsistency between the Plan and this Agreement, the terms of the Plan shall control. 

ARTICLE 2. 

PERFORMANCE SHARES 
 2.1 Grant of Performance Shares. In consideration of the Participant’s past and/or continued employment with the Company or an Affiliate and for other good and valuable consideration,
effective as of the Grant Date, the Company grants to the Participant an award of Performance Shares (this “Award”) as set forth in the Grant Notice, upon the terms and conditions set forth in the Plan and this Agreement.

  
 A-1

 2.2 Vesting; Payment. 

(a) Vesting. Subject to and conditioned upon the Participant’s continued employment with the Company or an Affiliate of the
Company through an applicable Vesting Date, a number of Performance Shares shall vest and become payable on such Vesting Date equal to the product, rounded down to the nearest whole Share, of: (i) the Reference Number (as may be adjusted by the
Administrator in connection with any accelerated vesting, if any), times (ii) the difference obtained by subtracting (A) the lesser of the Maximum Stock Price and the Fair Market Value as of such Vesting Date,
minus (B) the Baseline Stock Price, divided by (iii) the Fair Market Value as of such Vesting Date. For the avoidance of doubt, if the Baseline Stock Price is equal to or exceeds the Fair Market Value as of such
Vesting Date, then no Performance Shares shall vest or become payable on or in connection with such Vesting Date. 
 (b)
Payment. To the extent that any Performance Shares vest and become payable on any Vesting Date, such Performance Shares shall be paid in whole Shares on or within thirty (30) days after the applicable Vesting Date. The Company shall
deliver any Shares payable pursuant to this Section 2.2(b) (if any) to the Participant either by delivering one or more certificates for such Shares or by entering such Shares in book entry form, as determined by the Administrator in its sole
discretion. 
 (c) Performance Share Maximum. Notwithstanding the foregoing or anything contained herein, the maximum
number of Performance Shares that may vest and become payable hereunder (and the corresponding maximum number of Shares that may be delivered hereunder) shall not exceed the Maximum Number of Performance Shares set forth on the Grant Notice.

 2.3 Forfeiture. 
 (a) Termination of Employment. In the event that the Participant experiences a termination of employment during the Performance Period, any Performance Shares that have not vested and become
payable as of such termination of employment (after taking into consideration any accelerated vesting that may occur in connection with such termination, if any) shall thereupon automatically be forfeited by the Participant as of the date of
termination and the Participant’s rights and interests in any such Performance Shares and such portion of the Award shall thereupon lapse and expire. 
 (b) Expiration of Performance Period. Any Performance Shares that have not vested and become payable as of the expiration of the Performance Period on
[                ] (after taking into consideration any vesting that may occur on such Vesting Date), to the extent not previously forfeited, shall automatically be
forfeited by the Participant upon the expiration of the Performance Period and the Participant’s rights and interests in any such Performance Shares and such portion of the Award shall thereupon lapse and expire. 

2.4 Rights as Stockholder. The holder of the Performance Shares shall not be, nor have any of the rights or privileges of, a
stockholder of the Company, including, without limitation, voting rights and rights to dividends, in respect of the Performance Shares and any Shares underlying the Performance Shares and deliverable hereunder unless and until such Shares shall have
been issued by the Company and held of record by such holder (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company). 

  
 A-2

 ARTICLE 3. 
 OTHER PROVISIONS 
 3.1 Administration. The Administrator shall have
the power to interpret the Plan and this Agreement and to adopt such rules for the administration, interpretation and application of the Plan and this Agreement as are consistent therewith and to interpret, amend or revoke any such rules. Without
limiting the generality of the foregoing, all determinations, interpretations and assumptions relating to the calculation and payment of the Performance Shares shall be made by the Administrator. All actions taken and all interpretations and
determinations made by the Administrator in good faith shall be final and binding upon the Participant, the Company and all other interested persons. No member of the Administrator or the Board shall be personally liable for any action,
determination or interpretation made in good faith with respect to the Plan, this Agreement or the Performance Shares. 
 3.2
Grant is Not Transferable. During the lifetime of the Participant, the Performance Shares may not be sold, pledged, assigned or transferred in any manner other than by will or the laws of descent and distribution, unless and until the Shares
underlying the Performance Shares have been issued. Neither the Performance Shares nor any interest or right therein shall be liable for the debts, contracts or engagements of the Participant or his or her successors in interest or shall be subject
to disposition by transfer, alienation, anticipation, pledge, encumbrance, assignment or any other means whether such disposition be voluntary or involuntary or by operation of law by judgment, levy, attachment, garnishment or any other legal or
equitable proceedings (including bankruptcy), and any attempted disposition thereof shall be null and void and of no effect, except to the extent that such disposition is permitted by the preceding sentence. 

3.3 Adjustments. The Participant acknowledges that this Award and the Performance Shares are subject to amendment, modification
and termination in certain events as provided in this Agreement and Article 13 of the Plan. 
 3.4 Tax Withholding. The
Company or its Affiliates shall be entitled to require a cash payment by or on behalf of the Participant and/or to deduct from other compensation payable to the Participant any sums required by federal, state or local tax law to be withheld with
respect to the grant, vesting or payment of the Award. In satisfaction of the foregoing requirement with respect to the grant, vesting or payment of the Award, unless otherwise determined by the Administrator, the Company or its Affiliates shall
withhold Shares otherwise issuable under the Award having a fair market value equal to the sums required to be withheld by federal, state and/or local tax law. The number of Shares which shall be so withheld in order to satisfy such federal, state
and/or local withholding tax liabilities shall be limited to the number of shares which have a fair market value on the date of withholding equal to the aggregate amount of such liabilities based on the minimum statutory withholding rates for
federal, state and/or local tax purposes that are applicable to such supplemental taxable income. Notwithstanding any other provision of this Agreement, the Company shall not be obligated to deliver any certificate representing Shares to the
Participant or the Participant’s legal representative or to enter any such Shares in book entry form unless and until the Participant or the Participant’s legal representative, as applicable, shall have paid or otherwise satisfied in full
the amount of all federal, state and local taxes applicable to the taxable income of the Participant resulting from the grant or vesting of the Award or the issuance of Shares hereunder. 

3.5 Conditions to Delivery of Shares. The Shares deliverable under this Award may be either previously authorized but unissued
Shares, treasury Shares or Shares purchased on the open market. Such Shares shall be fully paid and nonassessable. The Company shall not be required to issue or deliver any certificates or make any book entries evidencing Shares under this Award
prior to fulfillment of the conditions set forth in Section 11.4 of the Plan. 

  
 A-3

 3.6 Notices. Any notice to be given under the terms of this Agreement shall be
addressed to the Company in care of the Secretary of the Company at the Company’s principal office (or the Secretary’s email), and any notice to be given to the Participant shall be addressed to the Participant’s last address
reflected on the Company’s records (or the Participant’s Company email or, if the Participant no longer has a Company email address, to the email address provided by the Participant at the time of his or her Termination of Service). Any
notice shall be deemed duly given when sent via email or when sent by reputable overnight courier or by certified mail (return receipt requested) through the United States Postal Service. 

3.7 Titles. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of
this Agreement. 
 3.8 Governing Law. The laws of the State of Delaware shall govern the interpretation, validity,
administration, enforcement and performance of the terms of this Agreement regardless of the law that might be applied under principles of conflicts of laws. 
 3.9 Conformity to Securities Laws. The Participant acknowledges that the Plan and this Agreement are intended to conform to the extent necessary with all provisions of the Securities Act and the
Exchange Act any and all regulations and rules promulgated by the Securities and Exchange Commission thereunder, and state securities laws and regulations. Notwithstanding anything herein to the contrary, the Plan shall be administered, and the
Award is granted, only in such a manner as to conform to such laws, rules and regulations. To the extent permitted by applicable law, the Plan and this Agreement shall be deemed amended to the extent necessary to conform to such laws, rules and
regulations. 
 3.10 Amendment, Suspension and Termination. To the extent permitted by the Plan, this Agreement may be
wholly or partially amended or otherwise modified, suspended or terminated at any time or from time to time by the Administrator or the Board; provided, however, that, except as may otherwise be provided by the Plan, no amendment,
modification, suspension or termination of this Agreement shall adversely affect the Award in any material way without the prior written consent of the Participant. 
 3.11 Successors and Assigns. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this Agreement shall inure to the benefit of the successors and
assigns of the Company. Subject to the restrictions on transfer set forth in Section 3.2 hereof, this Agreement shall be binding upon the Participant and his or her heirs, executors, administrators, successors and assigns. 

3.12 Limitations Applicable to Section 16 Persons. Notwithstanding any other provision of the Plan or this Agreement, if the
Participant is subject to Section 16 of the Exchange Act, then the Plan, the Award and this Agreement shall be subject to any additional limitations set forth in any applicable exemptive rule under Section 16 of the Exchange Act (including
any amendment to Rule 16b-3 of the Exchange Act) that are requirements for the application of such exemptive rule. To the extent permitted by applicable law, this Agreement shall be deemed amended to the extent necessary to conform to such
applicable exemptive rule. 
 3.13 No Continued Service. Nothing in this Agreement or in the Plan shall confer upon the
Participant any right to continue to serve as an Employee or other service provider of the Company or any of its Affiliates or shall interfere with or restrict in any way the rights of the Company and its

  
 A-4

 
Affiliates, which rights are hereby expressly reserved, to discharge or terminate the services of the Participant at any time for any reason whatsoever, with or without Cause, except to the
extent expressly provided otherwise in a written agreement between the Company or an Affiliate and the Participant. 
 3.14
Entire Agreement. The Plan, the Grant Notice and this Agreement (including all Exhibits thereto, if any) constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and
the Participant with respect to the subject matter hereof. 
 3.15 Section 409A. The Performance Shares are not
intended to constitute “nonqualified deferred compensation” within the meaning of Section 409A of the Code (together with any Department of Treasury regulations and other interpretive guidance issued thereunder, including without
limitation any such regulations or other guidance that may be issued after the date hereof, “Section 409A”). However, notwithstanding any other provision of the Plan or this Agreement, if at any time the Administrator
determines that the Performance Shares (or any portion thereof) may be subject to Section 409A, the Administrator shall have the right in its sole discretion (without any obligation to do so or to indemnify the Participant or any other person
for failure to do so) to adopt such amendments to the Plan or this Agreement, or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, as the Administrator determines
are necessary or appropriate for the Performance Shares to be exempt from the application of Section 409A or to comply with the requirements of Section 409A. 
 3.16 Limitation on the Participant’s Rights. Participation in the Plan confers no rights or interests other than as herein provided. This Agreement creates only a contractual obligation on the
part of the Company as to amounts payable and shall not be construed as creating a trust. The Plan, in and of itself, has no assets. The Participant shall have only the rights of a general unsecured creditor of the Company and its Affiliates with
respect to amounts credited and benefits payable, if any, with respect to the Shares issuable hereunder. 

  
 A-5

 EXHIBIT B 
 TO PERFORMANCE SHARE AWARD GRANT NOTICE 
 CONSENT OF SPOUSE

 I,
                    , spouse of
                    , have read and approve the Performance Share Award Grant Notice (the “Grant Notice”) to which this
Consent of Spouse is attached and the Performance Share Award Agreement (the “Agreement”) attached to the Grant Notice. In consideration of issuing to my spouse the shares of the common stock of Puma Biotechnology, Inc. set
forth in the Grant Notice, I hereby appoint my spouse as my attorney-in-fact in respect to the exercise of any rights under the Agreement and agree to be bound by the provisions of the Agreement insofar as I may have any rights in said Agreement or
any shares of the common stock of Puma Biotechnology, Inc. issued pursuant thereto under the community property laws or similar laws relating to marital property in effect in the state of our residence as of the date of the signing of the foregoing
Agreement. 
  

									
	Dated:	 	  
	 		 		 	  

		 		 		 		 	Signature of Spouse

  
 B-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}]]